Towards a Better Understanding of Genotype–Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction
Abstract
:1. Introduction
2. Desmosomal Genes
2.1. Reported DSP Variants
2.1.1. DSP Variants Causing DP Reduction
2.1.2. DSP Variants Causing an Altered DP Protein
2.1.3. Potential Therapeutic Avenues
2.2. Reported JUP Variants
2.2.1. JUP Variants Causing PG Reduction
2.2.2. JUP Variants Causing an Altered PG Protein
2.2.3. Potential Therapeutic Avenues
2.3. Reported DSC2 Variants
2.3.1. DSC2 Variants Causing DC2 Reduction
2.3.2. DSC2 Variants Causing an Altered DC2 Protein
2.3.3. Potential Therapeutic Avenues
3. Proteins Involved in Intermediate Filament Regulation
3.1. Reported KLHL24 Variants
3.1.1. KLHL24 Variants Causing KLHL24 Reduction
3.1.2. KLHL24 Variants Causing an Altered KLHL24 Protein
3.1.3. Potential Therapeutic Avenues
4. Gap Junction Genes
4.1. Reported GJA1 Variants
4.1.1. GJA1 Variants Causing Cx43 Reduction
4.1.2. GJA1 Variants Causing an Altered Cx43 Protein
4.1.3. Potential Therapeutic Avenues
5. Discussion
6. Materials and Methods
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Norgett, E.E. Recessive Mutation in Desmoplakin Disrupts Desmoplakin-Intermediate Filament Interactions and Causes Dilated Cardiomyopathy, Woolly Hair and Keratoderma. Hum. Mol. Genet. 2000, 9, 2761–2766. [Google Scholar] [CrossRef]
- Bolling, M.C.; Jonkman, M.F. Skin and Heart: Une Liaison Dangereuse. Exp. Dermatol. 2009, 18, 658–668. [Google Scholar] [CrossRef]
- Karmouch, J.; Zhou, Q.Q.; Miyake, C.Y.; Lombardi, R.; Kretzschmar, K.; Bannier-Hélaouët, M.; Clevers, H.; Wehrens, X.H.T.; Willerson, J.T.; Marian, A.J. Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes. Circ. Res. 2017, 121, 1346–1359. [Google Scholar] [CrossRef]
- Coulombe, P.A.; Kerns, M.L.; Fuchs, E. Epidermolysis Bullosa Simplex: A Paradigm for Disorders of Tissue Fragility. J. Clin. Investig. 2009, 119, 1784–1793. [Google Scholar] [CrossRef]
- Has, C.; Liu, L.; Bolling, M.C.; Charlesworth, A.V.; El Hachem, M.; Escámez, M.J.; Fuentes, I.; Büchel, S.; Hiremagalore, R.; Pohla-Gubo, G.; et al. Clinical Practice Guidelines for Laboratory Diagnosis of Epidermolysis Bullosa. Br. J. Dermatol. 2020, 182, 574–592. [Google Scholar] [CrossRef]
- Has, C.; Bauer, J.W.; Bodemer, C.; Bolling, M.C.; Bruckner-Tuderman, L.; Diem, A.; Fine, J.-D.; Heagerty, A.; Hovnanian, A.; Marinkovich, M.P.; et al. Consensus Reclassification of Inherited Epidermolysis Bullosa and Other Disorders with Skin Fragility. Br. J. Dermatol. 2020, 183, 614–627. [Google Scholar] [CrossRef]
- Fine, J.-D.; Bruckner-Tuderman, L.; Eady, R.A.J.; Bauer, E.A.; Bauer, J.W.; Has, C.; Heagerty, A.; Hintner, H.; Hovnanian, A.; Jonkman, M.F.; et al. Inherited Epidermolysis Bullosa: Updated Recommendations on Diagnosis and Classification. J. Am. Acad. Dermatol. 2014, 70, 1103–1126. [Google Scholar] [CrossRef]
- Asimaki, A.; Kleber, A.G.; Saffitz, J.E. Pathogenesis of Arrhythmogenic Cardiomyopathy. Can. J. Cardiol. 2015, 31, 1313–1324. [Google Scholar] [CrossRef]
- Protonotarios, N.; Tsatsopoulou, A. Naxos Disease and Carvajal Syndrome: Cardiocutaneous Disorders that Highlight the Pathogenesis and Broaden the Spectrum of Arrhythmogenic Right Ventricular Cardiomyopathy. Cardiovasc. Pathol. 2004, 13, 185–194. [Google Scholar] [CrossRef]
- Carvajal-Huerta, L. Epidermolytic Palmoplantar Keratoderma with Woolly Hair and Dilated Cardiomyopathy. J. Am. Acad. Dermatol. 1998, 39, 418–421. [Google Scholar] [CrossRef]
- McKoy, G.; Protonotarios, N.; Crosby, A.; Tsatsopoulou, A.; Anastasakis, A.; Coonar, A.; Norman, M.; Baboonian, C.; Jeffery, S.; McKenna, W.J. Identification of a Deletion in Plakoglobin in Arrhythmogenic Right Ventricular Cardiomyopathy with Palmoplantar Keratoderma and Woolly Hair (Naxos Disease). Lancet 2000, 355, 2119–2124. [Google Scholar] [CrossRef]
- Yenamandra, V.K.; van den Akker, P.C.; Lemmink, H.H.; Jan, S.Z.; Diercks, G.F.H.; Vermeer, M.; van den Berg, M.P.; van der Meer, P.; Pasmooij, A.M.G.; Sinke, R.J.; et al. Cardiomyopathy in Patients with Epidermolysis Bullosa Simplex with Mutations in KLHL24. Br. J. Dermatol. 2018, 179, 1181–1183. [Google Scholar] [CrossRef] [PubMed]
- Boyden, L.M.; Craiglow, B.G.; Zhou, J.; Hu, R.; Loring, E.C.; Morel, K.D.; Lauren, C.T.; Lifton, R.P.; Bilguvar, K.; Paller, A.S.; et al. Dominant de Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia. J. Investig. Dermatol. 2015, 135, 1540–1547. [Google Scholar] [CrossRef] [PubMed]
- Richards, S.; Aziz, N.; Bale, S.; Bick, D.; Das, S.; Gastier-Foster, J.; Grody, W.W.; Hegde, M.; Lyon, E.; Spector, E.; et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015, 17, 405–423. [Google Scholar] [CrossRef]
- Franken, R.; den Hartog, A.W.; Radonic, T.; Micha, D.; Maugeri, A.; van Dijk, F.S.; Meijers-Heijboer, H.E.; Timmermans, J.; Scholte, A.J.; van den Berg, M.P.; et al. Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome. Circ. Cardiovasc. Genet. 2015, 8, 383–388. [Google Scholar] [CrossRef]
- Getsios, S.; Huen, A.C.; Green, K.J. Working out the Strength and Flexibility of Desmosomes. Nat. Rev. Mol. Cell Biol. 2004, 5, 271–281. [Google Scholar] [CrossRef]
- Nekrasova, O.; Green, K.J. Desmosome Assembly and Dynamics. Trends Cell Biol. 2013, 23, 537–546. [Google Scholar] [CrossRef]
- Wan, H.; South, A.P.; Hart, I.R. Increased Keratinocyte Proliferation Initiated through Downregulation of Desmoplakin by RNA Interference. Exp. Cell Res. 2007, 313, 2336–2344. [Google Scholar] [CrossRef]
- Bryson, W.G.; Harland, D.P.; Caldwell, J.P.; Vernon, J.A.; Walls, R.J.; Woods, J.L.; Nagase, S.; Itou, T.; Koike, K. Cortical Cell Types and Intermediate Filament Arrangements Correlate with Fiber Curvature in Japanese Human Hair. J. Struct. Biol. 2009, 166, 46–58. [Google Scholar] [CrossRef]
- Thibaut, S.; Gaillard, O.; Bouhanna, P.; Cannell, D.W.; Bernard, B.A. Human Hair Shape Is Programmed from the Bulb. Br. J. Dermatol. 2005, 152, 632–638. [Google Scholar] [CrossRef]
- Thibaut, S.; Barbarat, P.; Leroy, F.; Bernard, B.A. Human Hair Keratin Network and Curvature. Int. J. Dermatol. 2007, 46, 7–10. [Google Scholar] [CrossRef] [PubMed]
- Gaul, R.T.; Nolan, D.R.; Ristori, T.; Bouten, C.V.C.; Loerakker, S.; Lally, C. Strain Mediated Enzymatic Degradation of Arterial Tissue: Insights into the Role of the Non-Collagenous Tissue Matrix and Collagen Crimp. Acta Biomater. 2018, 77, 301–310. [Google Scholar] [CrossRef] [PubMed]
- Stappenbeck, T.S.; Lamb, J.A.; Corcoran, C.M.; Green, K.J. Phosphorylation of the Desmoplakin COOH Terminus Negatively Regulates Its Interaction with Keratin Intermediate Filament Networks. J. Biol. Chem. 1994, 269, 29351–29354. [Google Scholar] [CrossRef]
- Yang, Z.; Bowles, N.E.; Scherer, S.E.; Taylor, M.D.; Kearney, D.L.; Ge, S.; Nadvoretskiy, V.V.; DeFreitas, G.; Carabello, B.; Brandon, L.I.; et al. Desmosomal Dysfunction Due to Mutations in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Circ. Res. 2006, 99, 646–655. [Google Scholar] [CrossRef] [PubMed]
- Rasmussen, T.; Hansen, J.; Nissen, P.; Palmfeldt, J.; Dalager, S.; Jensen, U.; Kim, W.; Heickendorff, L.; Mølgaard, H.; Jensen, H.; et al. Protein Expression Studies of Desmoplakin Mutations in Cardiomyopathy Patients Reveal Different Molecular Disease Mechanisms. Clin. Genet. 2013, 84, 20–30. [Google Scholar] [CrossRef]
- Notari, M.; Hu, Y.; Sutendra, G.; Dedeić, Z.; Lu, M.; Dupays, L.; Yavari, A.; Carr, C.A.; Zhong, S.; Opel, A.; et al. IASPP, a Previously Unidentified Regulator of Desmosomes, Prevents Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)-Induced Sudden Death. Proc. Natl. Acad. Sci. USA 2015, 112, E973–E981. [Google Scholar] [CrossRef]
- Basso, C. Ultrastructural Evidence of Intercalated Disc Remodelling in Arrhythmogenic Right Ventricular Cardiomyopathy: An Electron Microscopy Investigation on Endomyocardial Biopsies. Eur. Heart J. 2006, 27, 1847–1854. [Google Scholar] [CrossRef]
- Vermeer, M.C.S.C.; Andrei, D.; Kramer, D.; Nijenhuis, A.M.; Hoedemaekers, Y.M.; Westers, H.; Jongbloed, J.D.H.; Pas, H.H.; Berg, M.P.; Silljé, H.H.W.; et al. Functional Investigation of Two Simultaneous or Separately Segregating DSP Variants within a Single Family Supports the Theory of a Dose-dependent Disease Severity. Exp. Dermatol. 2022, 31, 970–979. [Google Scholar] [CrossRef]
- Bliley, J.M.; Vermeer, M.C.; Duffy, R.M.; Batalov, I.; Kramer, D.; Tashman, J.W.; Shiwarski, D.J.; Lee, A.; Teplenin, A.S.; Volkers, L.; et al. Dynamic Loading of Human Engineered Heart Tissue Enhances Contractile Function and Drives a Desmosome-Linked Disease Phenotype. Sci. Transl. Med. 2021, 13, eabd1817. [Google Scholar] [CrossRef]
- Lin, X.; Ma, Y.; Cai, Z.; Wang, Q.; Wang, L.; Huo, Z.; Hu, D.; Wang, J.; Xiang, M. Next-Generation Sequencing Identified Novel Desmoplakin Frame-Shift Variant in Patients with Arrhythmogenic Cardiomyopathy. BMC Cardiovasc. Disord. 2020, 20, 74. [Google Scholar] [CrossRef] [Green Version]
- Patel, D.M.; Dubash, A.D.; Kreitzer, G.; Green, K.J. Disease Mutations in Desmoplakin Inhibit Cx43 Membrane Targeting Mediated by Desmoplakin-EB1 Interactions. J. Cell Biol. 2014, 206, 779–797. [Google Scholar] [CrossRef] [PubMed]
- Whittock, N.V.; Ashton, G.H.S.; Dopping-Hepenstal, P.J.C.; Gratian, M.J.; Keane, F.M.; Eady, R.A.J.; McGrath, J.A. Striate Palmoplantar Keratoderma Resulting from Desmoplakin Haploinsufficiency. J. Investig. Dermatol. 1999, 113, 940–946. [Google Scholar] [CrossRef] [PubMed]
- Armstrong, D. Haploinsufficiency of Desmoplakin Causes a Striate Subtype of Palmoplantar Keratoderma. Hum. Mol. Genet. 1999, 8, 143–148, Erratum in Hum. Mol. Genet. 1999, 8, 943. [Google Scholar] [CrossRef] [PubMed]
- Wan, H.; Dopping-Hepenstal, P.J.C.J.C.; Gratian, M.J.J.; Stone, M.G.G.; Zhu, G.; Purkis, P.E.E.; South, A.P.P.; Keane, F.; Armstrong, D.K.B.K.B.; Buxton, R.S.S.; et al. Striate Palmoplantar Keratoderma Arising from Desmoplakin and Desmoglein 1 Mutations Is Associated with Contrasting Perturbations of Desmosomes and the Keratin Filament Network. Br. J. Dermatol. 2004, 150, 878–891. [Google Scholar] [CrossRef]
- Ng, R.; Manring, H.; Papoutsidakis, N.; Albertelli, T.; Tsai, N.; See, C.J.; Li, X.; Park, J.; Stevens, T.L.; Bobbili, P.J.; et al. Patient Mutations Linked to Arrhythmogenic Cardiomyopathy Enhance Calpain-Mediated Desmoplakin Degradation. JCI Insight 2019, 4, e128643. [Google Scholar] [CrossRef] [PubMed]
- Al-Jassar, C.; Knowles, T.; Jeeves, M.; Kami, K.; Behr, E.; Bikker, H.; Overduin, M.; Chidgey, M. The Nonlinear Structure of the Desmoplakin Plakin Domain and the Effects of Cardiomyopathy-Linked Mutations. J. Mol. Biol. 2011, 411, 1049–1061. [Google Scholar] [CrossRef]
- Boyden, L.M.; Kam, C.Y.; Hernández-Martín, A.; Zhou, J.; Craiglow, B.G.; Sidbury, R.; Mathes, E.F.; Maguiness, S.M.; Crumrine, D.A.; Williams, M.L.; et al. Dominant de Novo DSP Mutations Cause Erythrokeratodermia-Cardiomyopathy Syndrome. Hum. Mol. Genet. 2016, 25, 348–357. [Google Scholar] [CrossRef]
- Norman, M.; Simpson, M.; Mogensen, J.; Shaw, A.; Hughes, S.; Syrris, P.; Sen-Chowdhry, S.; Rowland, E.; Crosby, A.; McKenna, W.J. Novel Mutation in Desmoplakin Causes Arrhythmogenic Left Ventricular Cardiomyopathy. Circulation 2005, 112, 636–642. [Google Scholar] [CrossRef]
- Uzumcu, A.; Norgett, E.E.; Dindar, A.; Uyguner, O.; Nisli, K.; Kayserili, H.; Sahin, S.E.; Dupont, E.; Severs, N.J.; Leigh, I.M.; et al. Loss of Desmoplakin Isoform I Causes Early Onset Cardiomyopathy and Heart Failure in a Naxos-like Syndrome. J. Med. Genet. 2006, 43, e5. [Google Scholar] [CrossRef]
- Impact of the DSP-H1684R Genetic Variant on Ion Channels Activity in IPSC-Derived Cardiomyocytes. Cell. Physiol. Biochem. 2020, 54, 696–706. [CrossRef]
- Williams, T.; Machann, W.; Kühler, L.; Hamm, H.; Müller-Höcker, J.; Zimmer, M.; Ertl, G.; Ritter, O.; Beer, M.; Schönberger, J. Novel Desmoplakin Mutation: Juvenile Biventricular Cardiomyopathy with Left Ventricular Non-Compaction and Acantholytic Palmoplantar Keratoderma. Clin. Res. Cardiol. 2011, 100, 1087–1093. [Google Scholar] [CrossRef] [PubMed]
- Navarro-Manchón, J.; Fernández, E.; Igual, B.; Asimaki, A.; Syrris, P.; Osca, J.; Salvador, A.; Zorio, E. Miocardiopatía Arritmogénica Con Afectación Predominante del Ventrículo Izquierdo por una Mutación Nueva «sin Sentido» En Desmoplaquina. Rev. Española Cardiol. 2011, 64, 530–534. [Google Scholar] [CrossRef] [PubMed]
- Jonkman, M.F.; Pasmooij, A.M.G.; Pasmans, S.G.M.A.; van den Berg, M.P.; Ter Horst, H.J.; Timmer, A.; Pas, H.H. Loss of Desmoplakin Tail Causes Lethal Acantholytic Epidermolysis Bullosa. Am. J. Hum. Genet. 2005, 77, 653–660. [Google Scholar] [CrossRef] [PubMed]
- Mohammed, F.; Odintsova, E.; Chidgey, M. Missense Mutations in Desmoplakin Plakin Repeat Domains Have Dramatic Effects on Domain Structure and Function. Int. J. Mol. Sci. 2022, 23, 529. [Google Scholar] [CrossRef] [PubMed]
- Mahoney, M.G.; Sadowski, S.; Brennan, D.; Pikander, P.; Saukko, P.; Wahl, J.; Aho, H.; Heikinheimo, K.; Bruckner-Tuderman, L.; Fertala, A.; et al. Compound Heterozygous Desmoplakin Mutations Result in a Phenotype with a Combination of Myocardial, Skin, Hair, and Enamel Abnormalities. J. Investig. Dermatol. 2010, 130, 968–978. [Google Scholar] [CrossRef]
- Favre, B.; Begré, N.; Marsili, L.; van Tintelen, J.P.; Borradori, L. Desmoplakin Gene Variants and Risk for Arrhythmogenic Cardiomyopathy. Circ. Genom. Precis. Med. 2018, 11, e002241. [Google Scholar] [CrossRef]
- Favre, B.; Begré, N.; Borradori, L. A Recessive Mutation in the DSP Gene Linked to Cardiomyopathy, Skin Fragility and Hair Defects Impairs the Binding of Desmoplakin to Epidermal Keratins and the Muscle-Specific Intermediate Filament Desmin. Br. J. Dermatol. 2018, 179, 797–799. [Google Scholar] [CrossRef]
- Huen, A.C.; Park, J.K.; Godsel, L.M.; Chen, X.; Bannon, L.J.; Amargo, E.V.; Hudson, T.Y.; Mongiu, A.K.; Leigh, I.M.; Kelsell, D.P.; et al. Intermediate Filament–Membrane Attachments Function Synergistically with Actin-Dependent Contacts to Regulate Intercellular Adhesive Strength. J. Cell Biol. 2002, 159, 1005–1017. [Google Scholar] [CrossRef]
- Puzzi, L.; Borin, D.; Martinelli, V.; Mestroni, L.; Kelsell, D.P.; Sbaizero, O. Cellular Biomechanics Impairment in Keratinocytes Is Associated with a C-Terminal Truncated Desmoplakin: An Atomic Force Microscopy Investigation. Micron 2018, 106, 27–33. [Google Scholar] [CrossRef]
- Martherus, R.; Jain, R.; Takagi, K.; Mendsaikhan, U.; Turdi, S.; Osinska, H.; James, J.F.; Kramer, K.; Purevjav, E.; Towbin, J.A. Accelerated Cardiac Remodeling in Desmoplakin Transgenic Mice in Response to Endurance Exercise Is Associated with Perturbed Wnt/β-Catenin Signaling. Am. J. Physiol.-Heart Circ. Physiol. 2016, 38103, H174–H187. [Google Scholar] [CrossRef] [Green Version]
- Albrecht, L.V.; Zhang, L.; Shabanowitz, J.; Purevjav, E.; Towbin, J.A.; Hunt, D.F.; Green, K.J. GSK3- and PRMT-1-Dependent Modifications of Desmoplakin Control Desmoplakin-Cytoskeleton Dynamics. J. Cell Biol. 2015, 208, 597–612. [Google Scholar] [CrossRef] [PubMed]
- Lapouge, K.; Fontao, L.; Champliaud, M.-F.; Jaunin, F.; Frias, M.A.; Favre, B.; Paulin, D.; Green, K.J.; Borradori, L. New Insights into the Molecular Basis of Desmoplakinand Desmin-Related Cardiomyopathies. J. Cell Sci. 2006, 119, 4974–4985. [Google Scholar] [CrossRef] [PubMed]
- Dehner, C.; Rötzer, V.; Waschke, J.; Spindler, V. A Desmoplakin Point Mutation with Enhanced Keratin Association Ameliorates Pemphigus Vulgaris Autoantibody-Mediated Loss of Cell Cohesion. Am. J. Pathol. 2014, 184, 2528–2536. [Google Scholar] [CrossRef] [PubMed]
- Camors, E.M.; Purevjav, E.; Jefferies, J.L.; Saffitz, J.E.; Gong, N.; Ryan, T.D.; Lucky, A.W.; Taylor, M.D.; Sullivan, L.M.; Mestroni, L.; et al. Early Lethality Due to a Novel Desmoplakin Variant Causing Infantile Epidermolysis Bullosa Simplex with Fragile Skin, Aplasia Cutis Congenita, and Arrhythmogenic Cardiomyopathy. Circ. Genom. Precis. Med. 2020, 13, e002800. [Google Scholar] [CrossRef]
- Ian Gallicano, G.; Kouklis, P.; Bauer, C.; Yin, M.; Vasioukhin, V.; Degenstein, L.; Fuchs, E. Desmoplakin Is Required Early in Development for Assembly of Desmosomes and Cytoskeletal Linkage. J. Cell Biol. 1998, 143, 2009–2022. [Google Scholar] [CrossRef]
- Gomes, J.; Finlay, M.; Ahmed, A.K.; Ciaccio, E.J.; Asimaki, A.; Saffitz, J.E.; Quarta, G.; Nobles, M.; Syrris, P.; Chaubey, S.; et al. Electrophysiological Abnormalities Precede Overt Structural Changes in Arrhythmogenic Right Ventricular Cardiomyopathy Due to Mutations in Desmoplakin-A Combined Murine and Human Study. Eur. Heart J. 2012, 33, 1942–1953. [Google Scholar] [CrossRef]
- Garcia-Gras, E. Suppression of Canonical Wnt/ -Catenin Signaling by Nuclear Plakoglobin Recapitulates Phenotype of Arrhythmogenic Right Ventricular Cardiomyopathy. J. Clin. Investig. 2006, 116, 2012–2021. [Google Scholar] [CrossRef]
- Cheedipudi, S.M.; Hu, J.; Fan, S.; Yuan, P.; Karmouch, J.; Czernuszewicz, G.; Robertson, M.J.; Coarfa, C.; Hong, K.; Yao, Y.; et al. Exercise Restores Dysregulated Gene Expression in a Mouse Model of Arrhythmogenic Cardiomyopathy. Cardiovasc. Res. 2019, 116, 1199–1213. [Google Scholar] [CrossRef]
- Smith, E.A.; Fuchs, E. Defining the Interactions between Intermediate Filaments and Desmosomes. J. Cell Biol. 1998, 141, 1229–1241. [Google Scholar] [CrossRef]
- Lechler, T.; Fuchs, E. Desmoplakin: An Unexpected Regulator of Microtubule Organization in the Epidermis. J. Cell Biol. 2007, 176, 147–154. [Google Scholar] [CrossRef]
- Giuliodori, A.; Beffagna, G.; Marchetto, G.; Fornetto, C.; Vanzi, F.; Toppo, S.; Facchinello, N.; Santimaria, M.; Vettori, A.; Rizzo, S.; et al. Loss of Cardiac Wnt/β-Catenin Signalling in Desmoplakin-Deficient AC8 Zebrafish Models Is Rescuable by Genetic and Pharmacological Intervention. Cardiovasc. Res. 2018, 114, 1082–1097. [Google Scholar] [CrossRef] [PubMed]
- Li, D.; Zhang, W.; Liu, Y.; Haneline, L.S.; Shou, W. Lack of Plakoglobin in Epidermis Leads to Keratoderma. J. Biol. Chem. 2012, 287, 10435–10443. [Google Scholar] [CrossRef] [PubMed]
- Cabral, R.M.; Liu, L.; Hogan, C.; Dopping-Hepenstal, P.J.C.; Winik, B.C.; Asial, R.A.; Dobson, R.; Mein, C.A.; Baselaga, P.A.; Mellerio, J.E.; et al. Homozygous Mutations in the 5′ Region of the JUP Gene Result in Cutaneous Disease but Normal Heart Development in Children. J. Investig. Dermatol. 2010, 130, 1543–1550. [Google Scholar] [CrossRef] [PubMed]
- Asimaki, A.; Syrris, P.; Wichter, T.; Matthias, P.; Saffitz, J.E.; McKenna, W.J. A Novel Dominant Mutation in Plakoglobin Causes Arrhythmogenic Right Ventricular Cardiomyopathy. Am. J. Hum. Genet. 2007, 81, 964–973. [Google Scholar] [CrossRef] [PubMed]
- Huang, H.; Asimaki, A.; Lo, D.; McKenna, W.; Saffitz, J. Disparate Effects of Different Mutations in Plakoglobin on Cell Mechanical Behavior. Cell Motil. Cytoskelet. 2008, 65, 964–978. [Google Scholar] [CrossRef]
- Vahidnezhad, H.; Youssefian, L.; Faghankhani, M.; Mozafari, N.; Saeidian, A.H.; Niaziorimi, F.; Abdollahimajd, F.; Sotoudeh, S.; Rajabi, F.; Mirsafaei, L.; et al. Arrhythmogenic Right Ventricular Cardiomyopathy in Patients with Biallelic JUP-Associated Skin Fragility. Sci. Rep. 2020, 10, 21622. [Google Scholar] [CrossRef]
- Groeneweg, J.A.; Ummels, A.; Mulder, M.; Bikker, H.; van der Smagt, J.J.; van Mil, A.M.; Homfray, T.; Post, J.G.; Elvan, A.; van der Heijden, J.F.; et al. Functional Assessment of Potential Splice Site Variants in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Heart Rhythm 2014, 11, 2010–2017. [Google Scholar] [CrossRef]
- Pigors, M.; Kiritsi, D.; Krümpelmann, S.; Wagner, N.; He, Y.; Podda, M.; Kohlhase, J.; Hausser, I.; Bruckner-Tuderman, L.; Has, C. Lack of Plakoglobin Leads to Lethal Congenital Epidermolysis Bullosa: A Novel Clinico-Genetic Entity. Hum. Mol. Genet. 2011, 20, 1811–1819. [Google Scholar] [CrossRef]
- Liu, L.; Chen, C.; Li, Y.; Yu, R. Whole-Exome Sequencing Identified a De Novo Mutation of Junction Plakoglobin (p.R577C) in a Chinese Patient with Arrhythmogenic Right Ventricular Cardiomyopathy. Biomed. Res. Int. 2019, 2019, 9103860. [Google Scholar] [CrossRef]
- Kaplan, S.R.; Gard, J.J.; Protonotarios, N.; Tsatsopoulou, A.; Spiliopoulou, C.; Anastasakis, A.; Squarcioni, C.P.; McKenna, W.J.; Thiene, G.; Basso, C.; et al. Remodeling of Myocyte Gap Junctions in Arrhythmogenic Right Ventricular Cardiomyopathy Due to a Deletion in Plakoglobin (Naxos Disease). Heart Rhythm 2004, 1, 3–11. [Google Scholar] [CrossRef]
- Zhang, Z.; Stroud, M.J.; Zhang, J.; Fang, X.; Ouyang, K.; Kimura, K.; Mu, Y.; Dalton, N.D.; Gu, Y.; Bradford, W.H.; et al. Normalization of Naxos Plakoglobin Levels Restores Cardiac Function in Mice. J. Clin. Investig. 2015, 125, 1708–1712. [Google Scholar] [CrossRef] [PubMed]
- Protonotarios, N.; Tsatsopoulou, A.; Patsourakos, P.; Alexopoulos, D.; Gezerlis, P.; Simitsis, S.; Scampardonis, G. Cardiac Abnormalities in Familial Palmoplantar Keratosis. Heart 1986, 56, 321–326. [Google Scholar] [CrossRef] [PubMed]
- Asimaki, A.; Kapoor, S.; Plovie, E.; Karin Arndt, A.; Adams, E.; Liu, Z.; James, C.A.; Judge, D.P.; Calkins, H.; Churko, J.; et al. Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy. Sci. Transl. Med. 2014, 6, 240ra74. [Google Scholar] [CrossRef] [PubMed]
- Bierkamp, C.; McLaughlin, K.J.; Schwarz, H.; Huber, O.; Kemler, R. Embryonic Heart and Skin Defects in Mice Lacking Plakoglobin. Dev. Biol. 1996, 180, 780–785. [Google Scholar] [CrossRef] [PubMed]
- Ruiz, P.; Brinkmann, V.; Ledermann, B.; Behrend, M.; Grund, C.; Thalhammer, C.; Vogel, F.; Birchmeier, C.; Günthert, U.; Franke, W.W.; et al. Targeted Mutation of Plakoglobin in Mice Reveals Essential Functions of Desmosomes in the Embryonic Heart. J. Cell Biol. 1996, 135, 215–225. [Google Scholar] [CrossRef]
- Li, D.; Liu, Y.; Maruyama, M.; Zhu, W.; Chen, H.; Zhang, W.; Reuter, S.; Lin, S.-F.; Haneline, L.S.; Field, L.J.; et al. Restrictive Loss of Plakoglobin in Cardiomyocytes Leads to Arrhythmogenic Cardiomyopathy. Hum. Mol. Genet. 2011, 20, 4582–4596. [Google Scholar] [CrossRef]
- Swope, D.; Li, J.; Muller, E.J.; Radice, G.L. Analysis of a Jup Hypomorphic Allele Reveals a Critical Threshold for Postnatal Viability. Genesis 2012, 50, 717–727. [Google Scholar] [CrossRef]
- Kowalczyk, A.P.; Borgwardt, J.E.; Green, K.J. Analysis of Desmosomal Cadherin–Adhesive Function and Stoichiometry of Desmosomal Cadherin-Plakoglobin Complexes. J. Investig. Dermatol. 1996, 107, 293–300. [Google Scholar] [CrossRef]
- Christensen, A.H.; Schmitz, B.; Andersen, C.B.; Bundgaard, H.; Brand, S.-M.; Svendsen, J.H. Functional Promoter Variant in Desmocollin-2 Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy. Circ. Cardiovasc. Genet. 2016, 9, 384–387. [Google Scholar] [CrossRef]
- Lin, Y.; Huang, J.; Zhu, Z.; Zhang, Z.; Xian, J.; Yang, Z.; Qin, T.; Chen, L.; Huang, J.; Huang, Y.; et al. Overlap Phenotypes of the Left Ventricular Noncompaction and Hypertrophic Cardiomyopathy with Complex Arrhythmias and Heart Failure Induced by the Novel Truncated DSC2 Mutation. Orphanet J. Rare Dis. 2021, 16, 496. [Google Scholar] [CrossRef]
- Beffagna, G.; De Bortoli, M.; Nava, A.; Salamon, M.; Lorenzon, A.; Zaccolo, M.; Mancuso, L.; Sigalotti, L.; Bauce, B.; Occhi, G.; et al. Missense Mutations in Desmocollin-2 N-Terminus, Associated with Arrhythmogenic Right Ventricular Cardiomyopathy, Affect Intracellular Localization of Desmocollin-2 in Vitro. BMC Med. Genet. 2007, 8, 65. [Google Scholar] [CrossRef] [PubMed]
- Moreau, A.; Reisqs, J.; Delanoe-Ayari, H.; Pierre, M.; Janin, A.; Deliniere, A.; Bessière, F.; Meli, A.C.; Charrabi, A.; Lafont, E.; et al. Deciphering DSC2 Arrhythmogenic Cardiomyopathy Electrical Instability: From Ion Channels to ECG and Tailored Drug Therapy. Clin. Transl. Med. 2021, 11, e319. [Google Scholar] [CrossRef] [PubMed]
- Reisqs, J.; Moreau, A.; Charrabi, A.; Sleiman, Y.; Meli, A.C.; Millat, G.; Briand, V.; Beauverger, P.; Richard, S.; Chevalier, P. The PPARγ Pathway Determines Electrophysiological Remodelling and Arrhythmia Risks in DSC2 Arrhythmogenic Cardiomyopathy. Clin. Transl. Med. 2022, 12, e748. [Google Scholar] [CrossRef] [PubMed]
- Gehmlich, K.; Syrris, P.; Peskett, E.; Evans, A.; Ehler, E.; Asimaki, A.; Anastasakis, A.; Tsatsopoulou, A.; Vouliotis, A.-I.; Stefanadis, C.; et al. Mechanistic Insights into Arrhythmogenic Right Ventricular Cardiomyopathy Caused by Desmocollin-2 Mutations. Cardiovasc. Res. 2011, 90, 77–87. [Google Scholar] [CrossRef] [PubMed]
- Heuser, A.; Plovie, E.R.; Ellinor, P.T.; Grossmann, K.S.; Shin, J.T.; Wichter, T.; Basson, C.T.; Lerman, B.B.; Sasse-Klaassen, S.; Thierfelder, L.; et al. Mutant Desmocollin-2 Causes Arrhythmogenic Right Ventricular Cardiomyopathy. Am. J. Hum. Genet. 2006, 79, 1081–1088. [Google Scholar] [CrossRef]
- Gerull, B.; Kirchner, F.; Chong, J.X.; Tagoe, J.; Chandrasekharan, K.; Strohm, O.; Waggoner, D.; Ober, C.; Duff, H.J. Homozygous Founder Mutation in Desmocollin-2 (DSC2) Causes Arrhythmogenic Cardiomyopathy in the Hutterite Population. Circ. Cardiovasc. Genet. 2013, 6, 327–336. [Google Scholar] [CrossRef]
- Brodehl, A.; Weiss, J.; Debus, J.D.; Stanasiuk, C.; Klauke, B.; Deutsch, M.A.; Fox, H.; Bax, J.; Ebbinghaus, H.; Gärtner, A.; et al. A Homozygous DSC2 Deletion Associated with Arrhythmogenic Cardiomyopathy Is Caused by Uniparental Isodisomy. J. Mol. Cell. Cardiol. 2020, 141, 17–29. [Google Scholar] [CrossRef]
- Simpson, M.A.; Mansour, S.; Ahnood, D.; Kalidas, K.; Patton, M.A.; McKenna, W.J.; Behr, E.R.; Crosby, A.H. Homozygous Mutation of Desmocollin-2 in Arrhythmogenic Right Ventricular Cardiomyopathy with Mild Palmoplantar Keratoderma and Woolly Hair. Cardiology 2009, 113, 28–34. [Google Scholar] [CrossRef]
- Hamada, Y.; Yamamoto, T.; Nakamura, Y.; Sufu-Shimizu, Y.; Nanno, T.; Fukuda, M.; Ono, M.; Oda, T.; Okuda, S.; Ueyama, T.; et al. G790del Mutation in DSC2 Alone Is Insufficient to Develop the Pathogenesis of ARVC in a Mouse Model. Biochem. Biophys. Rep. 2020, 21, 100711. [Google Scholar] [CrossRef]
- Gehmlich, K.; Lambiase, P.D.; Asimaki, A.; Ciaccio, E.J.; Ehler, E.; Syrris, P.; Saffitz, J.E.; McKenna, W.J. A Novel Desmocollin-2 Mutation Reveals Insights into the Molecular Link between Desmosomes and Gap Junctions. Heart Rhythm 2011, 8, 711–718. [Google Scholar] [CrossRef] [Green Version]
- De Bortoli, M.; Beffagna, G.; Bauce, B.; Lorenzon, A.; Smaniotto, G.; Rigato, I.; Calore, M.; Li Mura, I.E.A.; Basso, C.; Thiene, G.; et al. The p.A897KfsX4 Frameshift Variation in Desmocollin-2 Is Not a Causative Mutation in Arrhythmogenic Right Ventricular Cardiomyopathy. Eur. J. Hum. Genet. 2010, 18, 776–782. [Google Scholar] [CrossRef] [PubMed]
- Rimpler, U. Funktionelle Charakterisierung von Desmocollin 2 Während Der Embryonalentwicklung und im Adulten Herzen in Der Maus. Ph.D. Thesis, Humboldt-Universität zu Berlin, Berlin, Germany, 2014. [Google Scholar]
- Brodehl, A.; Belke, D.D.; Garnett, L.; Martens, K.; Abdelfatah, N.; Rodriguez, M.; Diao, C.; Chen, Y.-X.; Gordon, P.M.K.; Nygren, A.; et al. Transgenic Mice Overexpressing Desmocollin-2 (DSC2) Develop Cardiomyopathy Associated with Myocardial Inflammation and Fibrotic Remodeling. PLoS ONE 2017, 12, e0174019. [Google Scholar] [CrossRef] [PubMed]
- Capetanaki, Y.; Papathanasiou, S.; Diokmetzidou, A.; Vatsellas, G.; Tsikitis, M. Desmin Related Disease: A Matter of Cell Survival Failure. Curr. Opin. Cell Biol. 2015, 32, 113–120. [Google Scholar] [CrossRef] [PubMed]
- Herrmann, H.; Burkhard, P.; Aebi, U.; Herrmann, H.; Strelkov, S.V.; Burkhard, P.; Aebi, U. Intermediate Filaments: Primary Determinants of Cell Architecture and Plasticity. J. Clin. Investig. 2009, 119, 1772–1783. [Google Scholar] [CrossRef]
- Hnia, K.; Ramspacher, C.; Vermot, J.; Laporte, J. Desmin in Muscle and Associated Diseases: Beyond the Structural Function. Cell Tissue Res. 2015, 360, 591–608. [Google Scholar] [CrossRef]
- Brodehl, A.; Gaertner-Rommel, A.; Milting, H. Molecular Insights into Cardiomyopathies Associated with Desmin (DES) Mutations. Biophys. Rev. 2018, 10, 983–1006. [Google Scholar] [CrossRef]
- Lin, Z.; Li, S.; Feng, C.; Yang, S.; Wang, H.; Ma, D.; Zhang, J.; Gou, M.; Bu, D.; Zhang, T.; et al. Stabilizing Mutations of KLHL24 Ubiquitin Ligase Cause Loss of Keratin 14 and Human Skin Fragility. Nat. Genet. 2016, 48, 1504–1516. [Google Scholar] [CrossRef]
- Shi, X.; Xiang, S.; Cao, J.; Zhu, H.; Yang, B.; He, Q.; Ying, M. Kelch-like Proteins: Physiological Functions and Relationships with Diseases. Pharmacol. Res. 2019, 148, 104404. [Google Scholar] [CrossRef]
- He, Y.; Maier, K.; Leppert, J.; Hausser, I.; Schwieger-Briel, A.; Weibel, L.; Theiler, M.; Kiritsi, D.; Busch, H.; Boerries, M.; et al. Monoallelic Mutations in the Translation Initiation Codon of KLHL24 Cause Skin Fragility. Am. J. Hum. Genet. 2016, 99, 1395–1404. [Google Scholar] [CrossRef]
- Vermeer, M.C.S.C.; Bolling, M.C.; Bliley, J.M.; Gomez, K.F.A.; Pavez-Giani, M.G.; Kramer, D.; Romero-Herrera, P.H.; Westenbrink, B.D.; Diercks, G.F.H.; van den Berg, M.P.; et al. Gain-of-Function Mutation in Ubiquitin Ligase KLHL24 Causes Desmin Degradation and Dilatation in HiPSC-Derived Engineered Heart Tissues. J. Clin. Investig. 2021, 131, e140615. [Google Scholar] [CrossRef]
- Vermeer, M.C.S.C.; Silljé, H.H.W.; Pas, H.H.; Andrei, D.; van der Meer, P.; Bolling, M.C. Keratin 14 Degradation and Aging in Epidermolysis Bullosa Simplex Due to KLHL24 Gain-of-Function Variants. J. Investig. Dermatol. 2022, 142, 2271–2274.e6. [Google Scholar] [CrossRef] [PubMed]
- Logli, E.; Marzuolo, E.; D’Agostino, M.; Conti, L.A.; Lena, A.M.; Diociaiuti, A.; Dellambra, E.; Has, C.; Cianfanelli, V.; Zambruno, G.; et al. Proteasome-Mediated Degradation of Keratins 7, 8, 17 and 18 by Mutant KLHL24 in a Foetal Keratinocyte Model: Novel Insight in Congenital Skin Defects and Fragility of Epidermolysis Bullosa Simplex with Cardiomyopathy. Hum. Mol. Genet. 2021, 11, 28. [Google Scholar] [CrossRef]
- Cui, J.; Zhao, Q.; Song, Z.; Chen, Z.; Zeng, X.; Wang, C.; Lin, Z.; Wang, F.; Yang, Y. KLHL24-Mediated Hair Follicle Stem Cells Structural Disruption Causes Alopecia. J. Investig. Dermatol. 2022, 142, 2079–2087.e8. [Google Scholar] [CrossRef] [PubMed]
- Vermeer, M.C.S.C.; Al-shinnag, M.; Silljé, H.H.W.; Gaytan, A.E.; Murrell, D.F.; McGaughran, J.; Melbourne, W.; Cowan, T.; van den Akker, P.C.; van Spaendonck-Zwarts, K.Y.; et al. A Translation Re-initiation Variant in KLHL24 Also Causes Epidermolysis Bullosa Simplex and Dilated Cardiomyopathy via Intermediate Filament Degradation. Br. J. Dermatol. 2022; Online ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Danielsson, O.; Hübbert, L.; Nennesmo, I.; Abramsson, A.; Banote, R.; Edling, M.; Zetterberg, H.; Oldfors, A. Hypertrophic Cardiomyopathy and Abnormal Glycogen Storage in Heart and Skeletal Muscle Associated with Inactivation of KLHL24. Neuromuscul. Disord. 2016, 26, S152. [Google Scholar] [CrossRef]
- Hedberg-Oldfors, C.; Abramsson, A.; Osborn, D.P.S.; Danielsson, O.; Fazlinezhad, A.; Nilipour, Y.; Hübbert, L.; Nennesmo, I.; Visuttijai, K.; Bharj, J.; et al. Cardiomyopathy with Lethal Arrhythmias Associated with Inactivation of KLHL24. Hum. Mol. Genet. 2019, 28, 1919–1929. [Google Scholar] [CrossRef]
- Alkhalifah, A.; Chiaverini, C.; Charlesworth, A.; Has, C.; Lacour, J.-P. Burnlike Scars: A Sign Suggestive of KLHL24-Related Epidermolysis Bullosa Simplex. Pediatr. Dermatol. 2018, 35, e193–e195. [Google Scholar] [CrossRef]
- Grilletta, E.A. Cardiac Transplant for Epidermolysis Bullosa Simplex with KLHL24 Mutation–Associated Cardiomyopathy. JAAD Case Rep. 2019, 5, 912–914. [Google Scholar] [CrossRef]
- SOHL, G.; Willecke, K. Gap Junctions and the Connexin Protein Family. Cardiovasc. Res. 2004, 62, 228–232. [Google Scholar] [CrossRef]
- Zhang, X.-F.; Cui, X. Connexin 43: Key Roles in the Skin. Biomed. Rep. 2017, 6, 605–611. [Google Scholar] [CrossRef] [Green Version]
- Avshalumova, L.; Fabrikant, J.; Koriakos, A. Overview of Skin Diseases Linked to Connexin Gene Mutations. Int. J. Dermatol. 2014, 53, 192–205. [Google Scholar] [CrossRef] [PubMed]
- Lilly, E.; Sellitto, C.; Milstone, L.M.; White, T.W. Connexin Channels in Congenital Skin Disorders. Semin. Cell Dev. Biol. 2016, 50, 4–12. [Google Scholar] [CrossRef] [PubMed]
- Michela, P.; Velia, V.; Aldo, P.; Ada, P. Role of Connexin 43 in Cardiovascular Diseases. Eur. J. Pharmacol. 2015, 768, 71–76. [Google Scholar] [CrossRef] [PubMed]
- Schinner, C.; Erber, B.M.; Yeruva, S.; Waschke, J. Regulation of Cardiac Myocyte Cohesion and Gap Junctions via Desmosomal Adhesion. Acta Physiol. 2019, 226, e13242. [Google Scholar] [CrossRef]
- Salameh, A.; Haunschild, J.; Bräuchle, P.; Peim, O.; Seidel, T.; Reitmann, M.; Kostelka, M.; Bakhtiary, F.; Dhein, S.; Dähnert, I. On the Role of the Gap Junction Protein Cx43 (GJA1) in Human Cardiac Malformations with Fallot-Pathology. A Study on Paediatric Cardiac Specimen. PLoS ONE 2014, 9, e95344. [Google Scholar] [CrossRef]
- Laird, D.W. Syndromic and Non-Syndromic Disease-Linked Cx43 Mutations. FEBS Lett. 2014, 588, 1339–1348. [Google Scholar] [CrossRef]
- Shao, Q.; Liu, Q.; Lorentz, R.; Gong, X.Q.; Bai, D.; Shaw, G.S.; Laird, D.W. Structure and Functional Studies of N-Terminal Cx43 Mutants Linked to Oculodentodigital Dysplasia. Mol. Biol. Cell 2012, 23, 3312–3321. [Google Scholar] [CrossRef]
- Churko, J.M.; Shao, Q.; Gong, X.Q.; Swoboda, K.J.; Bai, D.; Sampson, J.; Laird, D.W. Human Dermal Fibroblasts Derived from Oculodentodigital Dysplasia Patients Suggest That Patients May Have Wound-Healing Defects. Hum. Mutat. 2011, 32, 456–466. [Google Scholar] [CrossRef]
- Kelly, J.J.; Esseltine, J.L.; Shao, Q.; Jabs, E.W.; Sampson, J.; Auranen, M.; Bai, D.; Laird, D.W. Specific Functional Pathologies of Cx43 Mutations Associated with Oculodentodigital Dysplasia. Mol. Biol. Cell 2016, 27, 2172–2185. [Google Scholar] [CrossRef]
- Srinivas, M.; Jannace, T.F.; Cocozzelli, A.G.; Li, L.; Slavi, N.; Sellitto, C.; White, T.W. Connexin43 Mutations Linked to Skin Disease Have Augmented Hemichannel Activity. Sci. Rep. 2019, 9, 19. [Google Scholar] [CrossRef] [Green Version]
- Wang, H.; Cao, X.; Lin, Z.; Lee, M.; Jia, X.; Ren, Y.; Dai, L.; Guan, L.; Zhang, J.; Lin, X.; et al. Exome Sequencing Reveals Mutation in GJA1 as a Cause of Keratoderma-Hypotrichosis-Leukonychia Totalis Syndrome. Hum. Mol. Genet. 2015, 24, 243–250. [Google Scholar] [CrossRef] [PubMed]
- Shibayama, J.; Paznekas, W.; Seki, A.; Taffet, S.; Jabs, E.W.; Delmar, M.; Musa, H. Functional Characterization of Connexin43 Mutations Found in Patients with Oculodentodigital Dysplasia. Circ. Res. 2005, 96, e83–e91. [Google Scholar] [CrossRef] [PubMed]
- Falk, L.; Dang-Lawson, M.; Vega, J.L.; Pournia, F.; Choi, K.; Jang, C.; Naus, C.C.; Matsuuchi, L.M. Mutations of Cx43 That Affect B Cell Spreading in Response to BCR Signaling. Biol. Open 2014, 3, 185–191. [Google Scholar] [CrossRef]
- Gong, X.Q.; Shao, Q.; Langlois, S.; Bai, D.; Laird, D.W. Differential Potency of Dominant Negative Connexin43 Mutants in Oculodentodigital Dysplasia. J. Biol. Chem. 2007, 282, 19190–19202. [Google Scholar] [CrossRef]
- McLachlan, E.; Manias, J.L.; Gong, X.-Q.; Lounsbury, C.S.; Shao, Q.; Bernier, S.M.; Bai, D.; Laird, D.W. Functional Characterization of Oculodentodigital Dysplasia-Associated Cx43 Mutants. Cell Commun. Adhes. 2005, 12, 279–292. [Google Scholar] [CrossRef] [PubMed]
- Roscoe, W.; Veitch, G.I.L.; Gong, X.Q.; Pellegrino, E.; Bai, D.; McLachlan, E.; Shao, Q.; Kidder, G.M.; Laird, D.W. Oculodentodigital Dysplasia-Causing Connexin43 Mutants Are Non-Functional and Exhibit Dominant Effects on Wild-Type Connexin43. J. Biol. Chem. 2005, 280, 11458–11466. [Google Scholar] [CrossRef]
- Dobrowolski, R.; Sommershof, A.; Willecke, K. Some Oculodentodigital Dysplasia-Associated Cx43 Mutations Cause Increased Hemichannel Activity in Addition to Deficient Gap Junction Channels. J. Membr. Biol. 2007, 219, 9–17. [Google Scholar] [CrossRef]
- Huang, T.; Shao, Q.; MacDonald, A.; Xin, L.; Lorentz, R.; Bai, D.; Laird, D.W. Autosomal Recessive GJA1 (Cx43) Gene Mutations Cause Oculodentodigital Dysplasia by Distinct Mechanisms. J. Cell Sci. 2013, 126, 2857–2866. [Google Scholar] [CrossRef]
- Van Norstrand, D.W.; Asimaki, A.; Rubinos, C.; Dolmatova, E.; Srinivas, M.; Tester, D.J.; Saffitz, J.E.; Duffy, H.S.; Ackerman, M.J. Connexin43 Mutation Causes Heterogeneous Gap Junction Loss and Sudden Infant Death. Circulation 2012, 125, 474–481. [Google Scholar] [CrossRef]
- Lübkemeier, I.; Bosen, F.; Kim, J.S.; Sasse, P.; Malan, D.; Fleischmann, B.K.; Willecke, K. Human Connexin43E42K Mutation from a Sudden Infant Death Victim Leads to Impaired Ventricular Activation and Neonatal Death in Mice. Circ. Cardiovasc. Genet. 2015, 8, 21–29. [Google Scholar] [CrossRef] [Green Version]
- Tong, D.; Lu, X.; Wang, H.-X.; Plante, I.; Lui, E.; Laird, D.W.; Bai, D.; Kidder, G.M. A Dominant Loss-of-Function GJA1 (Cx43) Mutant Impairs Parturition in the Mouse1. Biol. Reprod. 2009, 80, 1099–1106. [Google Scholar] [CrossRef] [PubMed]
- Manias, J.L.; Plante, I.; Gong, X.-Q.; Shao, Q.; Churko, J.; Bai, D.; Laird, D.W. Fate of Connexin43 in Cardiac Tissue Harbouring a Disease-Linked Connexin43 Mutant. Cardiovasc. Res. 2008, 80, 385–395. [Google Scholar] [CrossRef] [PubMed]
- Huang, T.; Shao, Q.; Barr, K.; Simek, J.; Fishman, G.I.; Laird, D.W. Myogenic Bladder Defects in Mouse Models of Human Oculodentodigital Dysplasia. Biochem. J. 2014, 457, 441–449. [Google Scholar] [CrossRef] [PubMed]
- McLachlan, E.; Plante, I.; Shao, Q.; Tong, D.; Kidder, G.M.; Bernier, S.M.; Laird, D.W. ODDD-Linked Cx43 Mutants Reduce Endogenous Cx43 Expression and Function in Osteoblasts and Inhibit Late Stage Differentiation. J. Bone Miner. Res. 2008, 23, 928–938. [Google Scholar] [CrossRef]
- Kozoriz, M.G.; Lai, S.; Vega, J.L.; Sáez, J.C.; Sin, W.C.; Bechberger, J.F.; Naus, C.C. Cerebral Ischemic Injury Is Enhanced in a Model of Oculodentodigital Dysplasia. Neuropharmacology 2013, 75, 549–556. [Google Scholar] [CrossRef]
- Gregory, M.; Kahiri, C.N.; Barr, K.J.; Smith, C.E.; Hermo, L.; Cyr, D.G.; Kidder, G.M. Male Reproductive System Defects and Subfertility in a Mutant Mouse Model of Oculodentodigital Dysplasia. Int. J. Androl. 2011, 34, e630–e641. [Google Scholar] [CrossRef]
- Lorentz, R.; Shao, Q.; Huang, T.; Fishman, G.I.; Laird, D.W. Characterization of Gap Junction Proteins in the Bladder of Cx43 Mutant Mouse Models of Oculodentodigital Dysplasia. J. Membr. Biol. 2012, 245, 345–355. [Google Scholar] [CrossRef]
- Tuomi, J.M.; Tyml, K.; Jones, D.L. Atrial Tachycardia/Fibrillation in the Connexin 43 G60S Mutant (Oculodentodigital Dysplasia) Mouse. Am. J. Physiol. Circ. Physiol. 2011, 300, H1402–H1411. [Google Scholar] [CrossRef]
- Toth, K.; Shao, Q.; Lorentz, R.; Laird, D.W. Decreased Levels of Cx43 Gap Junctions Result in Ameloblast Dysregulation and Enamel Hypoplasia in Gja1Jrt/+ Mice. J. Cell. Physiol. 2010, 223, 601–609. [Google Scholar] [CrossRef]
- Churko, J.M.; Kelly, J.J.; Macdonald, A.; Lee, J.; Sampson, J.; Bai, D.; Laird, D.W. The G60S Cx43 Mutant Enhances Keratinocyte Proliferation and Differentiation. Exp. Dermatol. 2012, 21, 612–618. [Google Scholar] [CrossRef]
- Churko, J.M.; Chan, J.; Shao, Q.; Laird, D.W. The G60S Connexin43 Mutant Regulates Hair Growth and Hair Fiber Morphology in a Mouse Model of Human Oculodentodigital Dysplasia. J. Investig. Dermatol. 2011, 131, 2197–2204. [Google Scholar] [CrossRef] [PubMed]
- Winterhager, E.; Gellhaus, A.; Blois, S.M.; Hill, L.A.; Barr, K.J.; Kidder, G.M. Decidual Angiogenesis and Placental Orientation Are Altered in Mice Heterozygous for a Dominant Loss-of-Function Gja1 (Connexin43) Mutation1. Biol. Reprod. 2013, 89, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Abitbol, J.M.; Kelly, J.J.; Barr, K.J.; Allman, B.L.; Laird, D.W. Mice Harbouring an Oculodentodigital Dysplasia-Linked Cx43 G60S Mutation Have Severe Hearing Loss. J. Cell Sci. 2018, 131, jcs214635. [Google Scholar] [CrossRef] [PubMed]
- Flenniken, A.M.; Osborne, L.R.; Anderson, N.; Ciliberti, N.; Fleming, C.; Gittens, J.E.I.; Gong, X.Q.; Kelsey, L.B.; Lounsbury, C.; Moreno, L.; et al. A Gja1 Missense Mutation in a Mouse Model of Oculodentodigital Dysplasia. Development 2005, 132, 4375–4386. [Google Scholar] [CrossRef]
- Tong, D.; Colley, D.; Thoo, R.; Li, T.Y.; Plante, I.; Laird, D.W.; Bai, D.; Kidder, G.M. Oogenesis Defects in a Mutant Mouse Model of Oculodentodigital Dysplasia. DMM Dis. Model. Mech. 2009, 2, 157–167. [Google Scholar] [CrossRef]
- Hong, H.M.; Yang, J.J.; Shieh, J.C.; Li, M.L.; Li, S.Y. Novel Mutations in the Connexin43 (GJA1) and GJA1 Pseudogene May Contribute to Nonsyndromic Hearing Loss. Hum. Genet. 2010, 127, 545–551. [Google Scholar] [CrossRef]
- Kalcheva, N.; Qu, J.; Sandeep, N.; Garcia, L.; Zhang, J.; Wang, Z.; Lampe, P.D.; Suadicani, S.O.; Spray, D.C.; Fishman, G.I. Gap Junction Remodeling and Cardiac Arrhythmogenesis in a Murine Model of Oculodentodigital Dysplasia. Proc. Natl. Acad. Sci. USA 2007, 104, 20512–20516. [Google Scholar] [CrossRef]
- Paznekas, W.A.; Boyadjiev, S.A.; Shapiro, R.E.; Daniels, O.; Wollnik, B.; Keegan, C.E.; Innis, J.W.; Dinulos, M.B.; Christian, C.; Hannibal, M.C.; et al. Connexin 43 (GJA1) Mutations Cause the Pleiotropic Phenotype of Oculodentodigital Dysplasia. Am. J. Hum. Genet. 2003, 72, 408–418. [Google Scholar] [CrossRef]
- Dobrowolski, R.; Sasse, P.; Schrickel, J.W.; Watkins, M.; Kim, J.-S.; Rackauskas, M.; Troatz, C.; Ghanem, A.; Tiemann, K.; Degen, J.; et al. The Conditional Connexin43G138R Mouse Mutant Represents a New Model of Hereditary Oculodentodigital Dysplasia in Humans. Hum. Mol. Genet. 2008, 17, 539–554. [Google Scholar] [CrossRef]
- Dobrowolski, R.; Hertig, G.; Lechner, H.; Wörsdörfer, P.; Wulf, V.; Dicke, N.; Eckert, D.; Bauer, R.; Schorle, H.; Willecke, K. Loss of Connexin43-Mediated Gap Junctional Coupling in the Mesenchyme of Limb Buds Leads to Altered Expression of Morphogens in Mice. Hum. Mol. Genet. 2009, 18, 2899–2911. [Google Scholar] [CrossRef] [Green Version]
- Zheng, L.; Chenavas, S.; Kieken, F.; Trease, A.; Brownell, S.; Anbanandam, A.; Sorgen, P.L.; Spagnol, G. Calmodulin Directly Interacts with the Cx43 Carboxyl-Terminus and Cytoplasmic Loop Containing Three ODDD-Linked Mutants (M147T, R148Q, and T154A) That Retain α-Helical Structure, but Exhibit Loss-of-Function and Cellular Trafficking Defects. Biomolecules 2020, 10, 1452. [Google Scholar] [CrossRef] [PubMed]
- Esseltine, J.L.; Shao, Q.; Brooks, C.; Sampson, J.; Betts, D.H.; Séguin, C.A.; Laird, D.W. Connexin43 Mutant Patient-Derived Induced Pluripotent Stem Cells Exhibit Altered Differentiation Potential. J. Bone Miner. Res. 2017, 32, 1368–1385. [Google Scholar] [CrossRef] [PubMed]
- Kretz, M.; Maass, K.; Willecke, K. Expression and Function of Connexins in the Epidermis, Analyzed with Transgenic Mouse Mutants. Eur. J. Cell Biol. 2004, 83, 647–654. [Google Scholar] [CrossRef] [PubMed]
- Moorer, M.C.; Hebert, C.; Tomlinson, R.E.; Iyer, S.R.; Chason, M.; Stains, J.P. Defective Signaling, Osteoblastogenesis and Bone Remodeling in a Mouse Model of Connexin 43 C-Terminal Truncation. J. Cell Sci. 2017, 130, 531–540. [Google Scholar] [CrossRef]
- Gong, X.Q.; Shao, Q.; Lounsbury, C.S.; Bai, D.; Laird, D.W. Functional Characterization of a GJA1 Frameshift Mutation Causing Oculodentodigital Dysplasia and Palmoplantar Keratoderma. J. Biol. Chem. 2006, 281, 31801–31811. [Google Scholar] [CrossRef]
- Li, C.; Liang, J.; Chen, P.; Zeng, K.; Xue, R.; Tian, X.; Liang, L.; Wang, Q.; Shi, M.; Zhang, X. Two de Novo GJA1 Mutation in Two Sporadic Patients with Erythrokeratodermia Variabilis et Progressiva. Mol. Genet. Genomic Med. 2019, 7, e670. [Google Scholar] [CrossRef]
- Lucaciu, S.A.; Shao, Q.; Figliuzzi, R.; Barr, K.; Bai, D.; Laird, D.W. Interrogation of Carboxy-Terminus Localized GJA1 Variants Associated with Erythrokeratodermia Variabilis et Progressiva. Int. J. Mol. Sci. 2022, 23, 486. [Google Scholar] [CrossRef]
- Thibodeau, I.L.; Xu, J.; Li, Q.; Liu, G.; Lam, K.; Veinot, J.P.; Birnie, D.H.; Jones, D.L.; Krahn, A.D.; Lemery, R.; et al. Paradigm of Genetic Mosaicism and Lone Atrial Fibrillation: Physiological Characterization of a Connexin 43-Deletion Mutant Identified from Atrial Tissue. Circulation 2010, 122, 236–244. [Google Scholar] [CrossRef]
- Britz-Cunningham, S.H.; Shah, M.M.; Zuppan, C.W.; Fletcher, W.H. Mutations of the Connexin43 Gap-Junction Gene in Patients with Heart Malformations and Defects of Laterality. N. Engl. J. Med. 1995, 332, 1323–1330. [Google Scholar] [CrossRef]
- Ek-Vitorín, J.F.; Calero, G.; Morley, G.E.; Coombs, W.; Taffet, S.M.; Delmar, M. PH Regulation of Connexin43: Molecular Analysis of the Gating Particle. Biophys. J. 1996, 71, 1273–1284. [Google Scholar] [CrossRef] [Green Version]
- Langlois, S.; Maher, A.C.; Manias, J.L.; Shao, Q.; Kidder, G.M.; Laird, D.W. Connexin Levels Regulate Keratinocyte Differentiation in the Epidermis. J. Biol. Chem. 2007, 282, 30171–30180. [Google Scholar] [CrossRef] [PubMed]
- Wu, Q.; Wu, Y.; Zhang, L.; Zheng, J.; Tang, S.; Cheng, J. GJA1 Gene Variations in Sudden Unexplained Nocturnal Death Syndrome in the Chinese Han Population. Forensic Sci. Int. 2017, 270, 178–182. [Google Scholar] [CrossRef] [PubMed]
- Wittlieb-Weber, C.A.; Haude, K.M.; Fong, C.-T.; Vinocur, J.M. A Novel GJA1 Mutation Causing Familial Oculodentodigital Dysplasia with Dilated Cardiomyopathy and Arrhythmia. Heart Case Rep. 2016, 2, 32–35. [Google Scholar] [CrossRef] [PubMed]
- Izumi, K.; Lippa, A.M.; Wilkens, A.; Feret, H.A.; McDonald-McGinn, D.M.; Zackai, E.H. Congenital Heart Defects in Oculodentodigital Dysplasia: Report of Two Cases. Am. J. Med. Genet. Part A 2013, 161, 3150–3154. [Google Scholar] [CrossRef]
- Brnich, S.E.; Abou Tayoun, A.N.; Couch, F.J.; Cutting, G.R.; Greenblatt, M.S.; Heinen, C.D.; Kanavy, D.M.; Luo, X.; McNulty, S.M.; Starita, L.M.; et al. Recommendations for Application of the Functional Evidence PS3/BS3 Criterion Using the ACMG/AMP Sequence Variant Interpretation Framework. Genome Med. 2020, 12, 3. [Google Scholar] [CrossRef]
- Kidwai, F.K.; Liu, H.; Toh, W.S.; Fu, X.; Jokhun, D.S.; Movahednia, M.M.; Li, M.; Zou, Y.; Squier, C.A.; Phan, T.T.; et al. Differentiation of Human Embryonic Stem Cells into Clinically Amenable Keratinocytes in an Autogenic Environment. J. Investig. Dermatol. 2013, 133, 618–628. [Google Scholar] [CrossRef]
- Lee, J.; Rabbani, C.C.; Gao, H.; Steinhart, M.R.; Woodruff, B.M.; Pflum, Z.E.; Kim, A.; Heller, S.; Liu, Y.; Shipchandler, T.Z.; et al. Hair-Bearing Human Skin Generated Entirely from Pluripotent Stem Cells. Nature 2020, 582, 399–404. [Google Scholar] [CrossRef]
- Weinberger, F.; Mannhardt, I.; Eschenhagen, T. Engineering Cardiac Muscle Tissue: A Maturating Field of Research. Circ. Res. 2017, 120, 1487–1500. [Google Scholar] [CrossRef]
- Ronaldson-Bouchard, K.; Ma, S.P.; Yeager, K.; Chen, T.; Song, L.J.; Sirabella, D.; Morikawa, K.; Teles, D.; Yazawa, M.; Vunjak-Novakovic, G. Advanced Maturation of Human Cardiac Tissue Grown from Pluripotent Stem Cells. Nature 2018, 556, 239–243. [Google Scholar] [CrossRef]
- Landrum, M.J.; Lee, J.M.; Riley, G.R.; Jang, W.; Rubinstein, W.S.; Church, D.M.; Maglott, D.R. ClinVar: Public Archive of Relationships among Sequence Variation and Human Phenotype. Nucleic Acids Res. 2014, 42, D980–D985. [Google Scholar] [CrossRef] [Green Version]
- Abou Tayoun, A.N.; Pesaran, T.; DiStefano, M.T.; Oza, A.; Rehm, H.L.; Biesecker, L.G.; Harrison, S.M. Recommendations for Interpreting the Loss of Function PVS1 ACMG/AMP Variant Criterion. Hum. Mutat. 2018, 39, 1517–1524. [Google Scholar] [CrossRef] [PubMed]
- Biesecker, L.G.; Harrison, S.M. The ACMG/AMP Reputable Source Criteria for the Interpretation of Sequence Variants. Genet. Med. 2018, 20, 1687–1688. [Google Scholar] [CrossRef] [PubMed]
- Harrison, S.M.; Biesecker, L.G.; Rehm, H.L. Overview of Specifications to the ACMG/AMP Variant Interpretation Guidelines. Curr. Protoc. Hum. Genet. 2019, 103, e93. [Google Scholar] [CrossRef] [PubMed]
- Kumar, P.; Henikoff, S.; Ng, P.C. Predicting the Effects of Coding Non-Synonymous Variants on Protein Function Using the SIFT Algorithm. Nat. Protoc. 2009, 4, 1073–1081. [Google Scholar] [CrossRef]
- Adzhubei, I.A.; Schmidt, S.; Peshkin, L.; Ramensky, V.E.; Gerasimova, A.; Bork, P.; Kondrashov, A.S.; Sunyaev, S.R. A Method and Server for Predicting Damaging Missense Mutations. Nat. Methods 2010, 7, 248–249. [Google Scholar] [CrossRef]
- Pejaver, V.; Urresti, J.; Lugo-Martinez, J.; Pagel, K.A.; Lin, G.N.; Nam, H.; Mort, M.; Cooper, D.N.; Sebat, J.; Iakoucheva, L.M.; et al. MutPred2: Inferring the Molecular and Phenotypic Impact of Amino Acid Variants. Nat. Commun. 2020, 11, 5918. [Google Scholar] [CrossRef] [PubMed]
- Pagel, K.A.; Antaki, D.; Lian, A.; Mort, M.; Cooper, D.N.; Sebat, J.; Iakoucheva, L.M.; Mooney, S.D.; Radivojac, P. Pathogenicity and Functional Impact of Non-Frameshifting Insertion/Deletion Variation in the Human Genome. PLoS Comput. Biol. 2019, 15, e1007112. [Google Scholar] [CrossRef]
- Frischmeyer, P.A. Nonsense-Mediated MRNA Decayin Health and Disease. Hum. Mol. Genet. 1999, 8, 1893–1900. [Google Scholar] [CrossRef]
- Pagel, K.A.; Pejaver, V.; Lin, G.N.; Nam, H.-J.; Mort, M.; Cooper, D.N.; Sebat, J.; Iakoucheva, L.M.; Mooney, S.D.; Radivojac, P. When Loss-of-Function Is Loss of Function: Assessing Mutational Signatures and Impact of Loss-of-Function Genetic Variants. Bioinformatics 2017, 33, i389–i398. [Google Scholar] [CrossRef] [Green Version]
HGVS Nomenclature (DNA) | HGVS Nomenclature (Protein) |
Protein Domain |
ACMG Class |
In Silico Predictions |
Functional mRNA and Protein Studies | Biological Effect | Prediction: Functional | Skin | Heart |
---|---|---|---|---|---|---|---|---|---|
c.88G > A | p.(Val30Met) | N-terminus | B | >Protein expressed -PolyPhen-2> Benign (0.000) -SIFT> NOT tolerated -MutPred2> Benign (0.092) | Altered DP function; Mutant DP protein expressed, normal size and amount (WB) [24,25,26]. | Binding to PG abolished (Co-IP); DP localization in cytoplasm (transfection) [24]; DP normal in myocardial and epidermal tissue. Exhibit weaker binding to iASPP (transfection) [26]. Mouse DSPWT/88G > A [24]. | Match | (het) PPK; (het) WH2 | (het) ACM |
c.269A > G | p.(Gln90Arg) | N-terminus | B | >Protein expressed -PolyPhen-2> Probably damaging (0.967) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.757) | Altered DP function; Mutant DP protein expressed, normal size and amount (WB) [24,26]. | Binding to PG abolished (Co-IP); DP localization to cytoplasm (transfection) [24]. Mouse DSPWT/269A > G [24] | Match | n.s. | (het) ACM |
c.273 + 5G > A | Multiple splice products | Intron splice site (N-terminus) | US | -Human Splicing Finder> Broken WT donor site -MaxEntScan> Alteration of WT donor site, probably affecting splicing > Altered splicing, out of frame> PTC > NMD | Partial loss of DP: 20% less DP product on WB. No alternatively spliced transcripts discovered in patient-derived cells ([27,28], but did so in in vitro splicing assay (transfection). However, not functional [28]. | -In combination with c.6687del> Reduced DP protein on blot and staining in explanted heart and hiPSC-CMs and primary KCs [28,29]. -Dislocation of DP after 2D mechanical stretch; resulted in reduced count and density of desmosomes (EM) in dynamic EHTs leading to lower force and stress [29]. | Partial match, normal splicing left. | (comp.het) PPK; WH with DSP: c.6687delA | (comp.het) ACM/ NCCM :with DSP: c.6687delA |
c.699G > A | p.(Trp233*) | Plakin-domain | P | >PTC > NMD, no protein -MutPred-LOF> Borderline pathogenic (0.55385) | Partial loss of DP; Mutant RNA not detected in patient cells. Mutant DP is unstable (transfection-WB) [24]. | Perinuclear aggregates of DP (transfection IF) [24]. | Partial match, but not with transfection IF/WB | n.s. | (het) ACM |
c.832del | p.(Ala278Pro fs*39) | Plakin-domain | P | >PTC > NMD, no protein | Altered DP function; Truncated DP normally expressed and protein runs at 60 kDa (315 aa) (transfection-WB) -Leads to truncated DSP mRNA, also indicating that mRNA translation following the truncation was completely impaired. | c.832del overexpression led to upregulation of PG and downregulation of β-catenin in the nuclei, without affecting their expression in the cytoplasm (transfection) [30]. | Mismatch | n.s. | (het) ACM |
c.861T > G | p.(Asn287Lys) | Plakin-domain | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.997) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.699) | Altered DP function; Mutant DP expressed [31]. | Aberrant DP and Cx43 localization (transfection-IF) [31]. | Match | (hom)PPK; (hom)WH; (hom)EBS | n.o. |
c.897C > G | p.(Ser299Arg) | Plakin-domain | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.999) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.672) | Altered DP function; Mutant DP expressed [26]. | Exhibit weaker binding to iASPP = desmosome regulator (transfection) [26]. | Match | n.s. | (het) ACM |
c.939 + 1G > A | p.(Gln331*) | Donor site intron 7 (Plakin-domain) | P | >PTC > NMD, no protein | Partial loss of DP; Absence of detection of mRNA in multiple patient KCs, reported by two studies, suggests efficient NMD [32,33]. Only 20% DPI and 50% DPII is left on WB [34]. | -Major abnormalities in the spinous layer of the epidermis. The intercellular space is widened and KCs contain abnormal cytoplasmic densities [33]. -Small desmosomes and fewer in number; perinuclear keratin distribution 7. - DC3 seems reduced on WB; volume densities of desmosomal proteins seem different from control [34]. | Match | (het) PPK | n.r. |
c.969_974del | p.(Lys324_Glu325del) | Plakin-domain | LP | >Protein expressed -MutPred-Indel> Benign (0.19566) | Partial loss of DP; Reduced expression of both native DP isoforms in cytoskeletal and cytoplasmic protein fractions (WB) [25], suggesting instable protein> incomplete degradation. | DP expression was significantly reduced in myocardial tissue and epidermal biopsies (IF) [25]. | Mismatch | (hom)PPK; (hom)WH | (hom) ACM, bi-ventricular |
c.1348C > G | p.(Arg451Gly) | Plakin-domain | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.756) | Partial loss of DP; 50% reduced DPI&II protein in EHTs (WB) [35]. -mRNA levels of DSP not reduced compared to WT [35]. > instable protein degradation. | 50% reduced DP signal and 70% reduced Cx43 in myocardial tissues (IF); Proteolytic degradation by calpain, leading to DP insufficiency [35]. | Mismatch | n.r. | (het) ACM, bi-ventricular |
c.1372A > T | p.(Asn458Tyr) | Plakin-domain | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.939) -SIFT> Tolerated -MutPred2> Benign (0.323) | Altered DP function; Mutant DP expressed [31]. | Altered EB1 binding and Cx43 localization (transfection IF) [31]. | Match | n.o. | (het) ACM |
c.1408A > G | p.(Lys470Glu) | Plakin-domain | US | >Protein expressed -PolyPhen-2> Benign (0.082) -SIFT> Tolerated -MutPred2> Benign (0.408) | Altered DP function; Conformational alternation, but overall folded structure of DP is remained [36]. Mutant DP expressed (WB) [31]. | Mutant is incorporated into the desmosome [25]. | Match | n.s./n.o. | (hom) ACM |
c.1598T > C | p.(Ile533Thr) | Plakin-domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.998) -SIFT> NOT tolerated -MutPred2> Benign (0.442) | Altered DP function; Mutant DP expressed (WB) [31]. | Altered EB1 binding and Cx43 localization (transfection IF) [31]. | Match | n.o. | (het) ACM |
c.1696G > A | p.(Ala566Thr) | Plakin-domain | US | >Protein expressed -PolyPhen-2> Benign (0.007) -SIFT> Tolerated -MutPred2> Benign (0.153) | Altered DP function; Mutant DP expressed (WB) [31]. | Mutant is incorporated into the desmosome [25]. | Match | n.o. | (het) ACM |
c.1853A > C | p.(His618Pro) | Plakin-domain | LP | >Protein expressed -PolyPhen-2> Possibly damaging (0.602) -SIFT> NOT tolerated -MutPred2> Benign (0.540) | Altered DP function; Mutant DP expressed (WB) [37]. | Mutant localizes to membrane, affected Cx43 localization (transfection studies/skin biopsies). Desmosome aggregation [37]. | Match | (het) PPK; (het) WH; (het) EBS | (het) CM |
c.1865T > C | p.(Leu622Pro) | Plakin-domain | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.998) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.828) | Altered DP function; Mutant DP expressed (WB) [37]. | Mutant localizes to membrane, affected Cx43 localization (transfection studies/skin biopsies). Desmosome aggregation [37]. | Match | (het) PPK; (het) WH; (het) EBS | (het) CM |
c.1755dup | p.(His586Thr fs*9) | Plakin domain | P | >PTC > NMD, no protein | Altered DP function; Truncated DP protein, (65 kDa) (WB), truncation of ROD and C-terminus [38]. | n.r. | Mismatch | n.s. | (het) ACM, LV mostly |
c.2422C > T | p.(Arg808Cys) | Plakin-domain | US | >Protein expressed -PolyPhen-2> Benign (0.047) -SIFT> NOT tolerated -MutPred2> Benign (0.409) | Unclear; Conformational alteration (transfection), but overall folded structure of DP is remained [36]. Needs further confirmation in patient cells, whether expressed or not. | n.r. | Unclear | n.s. | (het) ACM |
c.3799C > T | p.(Arg1267*) | ROD domain (DPI) | P | >PTC > NMD, no protein -MutPred-LOF> Borderline pathogenic (0.5552) | Partial loss of DPI; Instable mutant DPI protein (NMD?) [39]. -Highly reduced DSP mRNA expression (NMD?) [39]. -Complete loss of DPI in patient skin, DPII has normal expression as expected (WB) [39]. | n.r. | Match | (hom)PPK epidermolytic; (hom)WH | (hom) ACM/ DCM |
c.3805C > T | p.(Arg1269*) | ROD domain (DPI) | P | >PTC > NMD, no protein -MutPred-LOF> Borderline pathogenic (0.55487) | Partial loss of DPI; Broken down by NMD. DPI/DPI-II protein ratios lower in variant carriers compared with WT individuals. -DPI/DPII expression ratio reduced by 28% in mutant cells. 15-fold lower mutant than WT [25]. | Decreased DP expression in endomyocardial biopsies. DPI deficiency (IF) [25]. | Match | (het) PPK; (het) WH | (het) DCM, bi-ventricular |
c.5051A > G | p.(His1684Arg) | ROD domain (DPI) | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.956) -SIFT> NOT tolerated -MutPred2> Benign (0.256) | Altered DPI function: No effect on amount or size of DPI protein on WB [40]. DPII should not be affected. | Affects action potential and duration; multiple ion channel dysfunction in hiPSC-CMs [40]. | Match | n.r. | (het) CM, conduction disease |
c.5208_5209del | p.(Gly1737Thrfs*7) | ROD domain (DPI) | P | >PTC > NMD, no protein | Partial loss of DPI/Unclear? Truncated DPI protein predicted to run at similar height as DPII, yet no increase in this band was observed in skin biopsies (WB) [41]. DPII should not be affected, but data are unclear. | n.r. | Unclear | (hom) PPK acantholytic; (hom)WH; | (hom) NCCM, bi-ventricular, severe |
c.5596C > T | p.(Gln1866*) | ROD domain (DPI) | LP | >PTC > terminal exon, NOT NMD > protein expressed | Altered DPI function; Truncated DPI protein (160 kDa) observed in skin biopsies [42]. DPII should not be affected. | n.r. | Match | n.s. | (het) ACM, LV dilation |
c.5800C > T | p.(Arg1934*) | ROD domain (DPI) | LP | >PTC > terminal exon, NOT NMD > protein expressed | Altered DPI function; Truncated DPI protein (243 kDa) (WB) [43]. DPII should not be affected. -Aberrant mRNA transcripts. Not NMD. | Stable expressed DP protein, which is recruited into desmosomes, although more punctate staining was observed (IF) [43]. | Match | (comp.het) (lethal) EBS, PPK and WH, with DSP: c.6091_6092del [43] | n.r. |
c.6091_6092del | p.(Leu2031Glyfs*29) | PRD (A domain) | LP | >PTC > terminal exon, NOT NMD > protein expressed | Altered DP function; Truncated DP-I protein (228 kDa) (WB) [43]. Not clear what happens with DPII. -Aberrant mRNA transcripts. Not NMD. | Stable expressed DP protein, which is recruited in desmosomes, although more punctate staining was observed (IF) [43]. | Match | (comp.het) (lethal) EBS, PPK; and WH, with DSP: c.5800C > T [43] | n.r. |
c.6166G > C | p.(Gly2056Arg) | PRD (A domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.872) | Altered DP function; Expressed in insoluble fraction of bacterial cells (transfection WB) [44]. Low expression in HeLa cells. Likely expressed mutant. | n.r. | Probable match | (hom) PPK | (hom) ACM, LV involvement |
c.6247C > T | p.(Arg2083Cys) | PRD (A domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Benign (0.443) | Altered DP function; Expressed in soluble fraction of bacterial cells (transfection WB), thus correctly folded [44]. Likely expressed mutant, needs confirmation in patient cells. | n.r. | Probable match | n.r. | (het) LQTS |
c.6307A > G | p.(Lys2103Glu) | PRD (A domain) | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.860) -SIFT> Tolerated -MutPred2> Benign (0.417) | Altered DP function; Expressed in soluble fraction of bacterial cell transfection, thus correctly folded (WB) [44]. Likely expressed mutant, needs confirmation in patient cells. | n.r. | Probable match | n.r. | (het) DCM |
c.6310del | p.(Thr2104Glnfs*12) | PRD (A domain) | LP | >PTC > terminal exon, NOT NMD > protein expressed | Altered DP function; Several truncated DP proteins shown on WB, but mutant is predicted to be 238 kDa [45] | Fibrosis and fat deposition in the heart with reduction in Cx43, disorganized IDs, but staining of DP, PG and DG2 seemed normal; severe reduction of DPI&II on IF ex vivo skin. β-catenin expression was also reduced on IF in skin [45]. | Match | (comp.het) EBS, PPK and WH: with DSP: c.7964C > A | (comp.het) Bi-ventricular CM: with DSP: c.7964C > A |
c.6577G > A | p.(Glu2193Lys) | PRD (A domain) | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.950) -SIFT> Tolerated -MutPred2> Benign (0.346) | Altered DP function; Expressed in insoluble fraction in bacterial cells (transfection WB) [44]. Likely expressed mutant, needs confirmation in patient cells. | n.r. | Probable match | (comp.het) Alopecia PPK, with DSP:c.7567delAAGA | (comp.het) DCM, with DSP:c.7567delAAGA |
c.6687del | p.(Arg2229Serfs*32) | PRD (B domain) | LP | >PTC > terminal exon, NOT NMD > protein expressed | Partial loss of DP: NMD of product (WB, NMD inhibitor exp.), 50% reduced protein levels [28,29]. -mRNA 50% reduced [29]. | -Reduced DP protein on blot and staining in explanted heart, hiPSC-CMs and primary KCs [28,29]. -Mislocalisation of DP after 2D mechanical stretch; in combination with c.273 + 5G > A resulted in reduced count and density of desmosomes in hiPSC-derived dynamic EHTs leading to lower force and stress [29] -Faster differentiation observed in primary KCs of patients. Mechanical stretch provoked cell-contact defects [28]. | Mismatch NMD active in terminal exon! | (het)PPK; (comp.het)WH: with DSP: c.273 + 5G > A | Lethal ACM/ NCCM (comp.het) ACM/ NCCM (bi-ventricular) (het) |
c.6885A > T | p.(Gln2295His) | PRD (B domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (0.999) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.833) | Altered DP function; Likely truncated DP protein expressed. | Severe binding deficiency with intermediate filaments (transfection IF) [46]. | Probable match | n.r. | (hom) DCM |
c.7012G > A | p.(Gly2338Arg) | PRD (B domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.910) | Altered DP function; Insoluble fraction in bacterial cell transfection (WB) [44]. Likely expressed mutant, needs confirmation in patient cells. | n.r. | Probable match | n.r. | (het) CM |
c.7027G > A | p.(Glu2343Lys) | PRD (B domain) | US | >Protein expressed -PolyPhen-2> Benign (0.077) -SIFT> Tolerated -MutPred2> Benign (0.386) | Altered DP function; Likely truncated DP protein expressed. Soluble fraction in bacterial cell transfection, thus correctly folded (WB) [44]. | Altered binding with vimentin and keratin8/18 (transfection IF) [46]. | Probable match | n.r. | (het) ACM ACM, with PKP2:c.1468C > T |
c.7096C > T | p.(Arg2366Cys) | PRD (B domain) | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.980) -SIFT> NOT tolerated -MutPred2> Benign (0.622) | Altered DP function; Likely truncated DP protein expressed [46]. Soluble fraction of bacterial cell transfection (WB) [44]. High expression in HeLa cells. Needs confirmation in patient cells. | Severe binding deficiency with intermediate filaments (transfection IF) [46]. No binding deficiency with vimentin (IF transfection) [44]. | Probable match | (hom)EBS; (hom)PPK; (hom)WH | n.r. |
c.7123G > C | p.(Gly2375Arg) | PRD (B domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.938) | Altered DP function; Truncated DP protein expressed [47]. Insoluble fraction of bacterial cell transfection (WB) [44]. | Co-alignment with IFs severely affected. Diffuse cytosolic distributed [47]. Targeting to IFs affected (transfection-IF) [44]. | Match | (hom)EBS; (hom)PPK; (hom)WH | (hom)ACM |
c.7534G > T | p.(Asp2512Tyr) | Linkers | US | >Protein expressed -PolyPhen-2> Probably damaging (0.998) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.825) | Unclear; Likely truncated DP protein expressed. Needs further confirmation in patient cells. | No binding deficiency with IFs (transfection-IF) [46]. | Unclear | n.o. | n.o. |
c.7623G > T | p.(Arg2541Ser) | Linkers | US | >Protein expressed -PolyPhen-2> Benign (0.010) -SIFT> NOT tolerated -MutPred2> Benign (0.265) | Unclear; Likely truncated DP protein expressed. Needs further confirmation in patient cells. | No binding deficiency with IFs (transfection-IF) [46]. | Unclear | n.r. | (het) ACM |
c.7623del | p.(Lys2542Serfs*19) | Linkers | LP | >PTC > terminal exon, NOT NMD > protein expressed | Altered DP function; Severe reduction of both DPI&II (WB), both truncated proteins detected [25]. | Normal DP immunoreactivity in epidermal and myocardial tissue (IF)/or almost no signal depending on homozygous or heterozygous patient [25]. | Match | (hom)PPK; (hom)WH | (hom) ACM, bi-ventricular |
c.7780del | p.(Ser2594Profs*9) | Linkers | LP | >PTC > terminal exon, NOT NMD > protein expressed | Altered DP function; Truncated DP protein, 18 aa downstream of deletion (WB) [1]. | Partial disruption with intermediate filament binding (IF) [1]; KCs have alteration in morphology, elasticity, adhesion capabilities and viscoelastic properties [48,49]. | Match | (hom)PPK; (hom)WH | (hom) DCM |
c.7916G > A | p.(Arg2639Gln) | PRD (C domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (0.978) -SIFT > Tolerated -MutPred2> Benign (0.484) | Altered DP function; Likely truncated DP proteins expressed [46]. Expressed in soluble fraction in bacterial cells (transfection WB) [44]. | Altered binding with desmin and keratin8/18 (transfection IF) [46]. No binding deficiency with vimentin (IF transfection) [44]. | Probable match | n.r. | (het) CM; RV dysfunction |
c.7940G > A | p.(Gly2647Asp) | PRD (C domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (0.980) -SIFT> NOT tolerated -MutPred2> Benign (0.619) | Altered DP function: Both in insoluble and soluble fraction in bacterial cells (transfection WB) [44]. Likely expressed mutant. | n.r. | Probable match | n.r. | (het) CM |
c.7964C > A | p.(Ala2655Asp) | PRD (C domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (0.999) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.754) | Altered DP function; Likely truncated DP proteins expressed, as full loss of protein is not expected due to recessive inheritance. | Severe binding deficiency with intermediate filaments (transfection IF) [46]. | Probable match | (hom)EBS; (hom)PPK; (hom)WH | (hom) ACM, bi-ventricular |
c.8066A > C | p.(Lys2689Thr) | PRD (C domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT > Tolerated -MutPred2> Benign (0.625) | Altered DP function: Expressed in soluble fraction in bacterial cells (transfection WB), thus correctly folded [44]. High expression in HeLa cells. Likely expressed mutant. Needs confirmation in patient cells. | No binding deficiency with vimentin (transfection IF) [44]. | Probable match | n.r. | (het) ACM |
c.8275C > A | p.(Arg2759Ser) | PRD (C domain) | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT > Tolerated -MutPred2> Benign (0.350) | Altered DP function: Expressed in soluble fraction in bacterial cells (transfection, thus correctly folded WB) [44]. Likely expressed mutant. Needs confirmation in patient cells. | n.r. | Probable match | n.r. | (het) ACM |
c.8501G > A | p.(Arg2834His) | C- terminus | US | >Protein expressed -PolyPhen-2> Probably damaging (0.972) -SIFT> NOT tolerated -MutPred2> Benign (0.189) | Altered DP function; C-terminally truncated DP protein (WB) [24]. | Aberrant IF localization; DP localization at cell membrane; affects other junctional proteins [24]; Arg2834His blocked the GSK3β phosphorylation cascade and reduced DP–GSK3β interactions in KCs and in hearts of Arg2834His DP mice [18]. Mouse DSPWT/8501G > A [24,50,51] | Match | n.s. | (het) ACM |
Engineered variant | p.(Ser2849Gly) | C- terminus | n.a. | >Protein expressed -PolyPhen-2> Probably damaging (0.978) -SIFT> NOT tolerated -MutPred2> Benign (0.344) | Altered DP function; Mutant DP protein detected (WB), normal size. | Mutant DP exhibits increased anchorage of keratin/desmin [52] filaments and fosters calcium independency [53]. | n.a. | unknown | unknown |
c.8576_8577del | p.(Ser2859Leufs*6) | C- terminus | LP | >PTC > terminal exon, NOT NMD > protein expressed | Altered DP function; Highly reduced mutant DP protein detected in insoluble fraction (WB), none in soluble fraction, but normal size (only 2859 + 6 aa, compared to wildtype 2871 aa) | GSK3β, normally phosphorylates Ser2859Leu, translocated to the soluble fraction of patient extract where its high activity (dephosph). Ser9 was associated with the phosphorylation (Ser33/37-Thr41) and degradation of β-catenin; abolition of β-catenin phosphorylation in the non-soluble fraction was associated with its translocation into CMs nuclei [54]. | Match | (hom and het) EBS | (hom and het) ACM |
HGVS Nomenclature (DNA) |
HGVS Nomenclature (Protein) |
Protein Domain |
ACMG Class |
In Silico Predictions |
Functional mRNA and Protein Studies | Biological Effect | Prediction: Functional | Skin | Heart |
---|---|---|---|---|---|---|---|---|---|
c.71C > A | p.(Glu2_Met43del) not p.(Ser24*) as predicted | Head domain | LP | >PTC > NMD, no protein -MutPred-LOF> too short sequence for prediction | Altered PG function; Truncated N-terminal protein (lacking the first 42 aa, translation re-initiation Met43) with reduced expression in the skin (WB) [63]. -Similar JUP mRNA levels as in control [63]. | Reduced PG expression (IF; WB) and disrupted distribution of DP and DG1 (IF) [63]. | Mismatch | (hom)EBS; (hom)PPK; (hom)WH | n.o. |
c.116_118dup | p.(Ser39dup) | Head domain | US | >Protein expressed -MutPred-Indel> Pathogenic (0.76492) | Altered PG function: Mutant PG protein size similar as WT (82 kDa; WB) [64,65]. See comment on biological effect [65]. | -Patient heart displayed a decrease in signal of DP, PG and Cx43 (IF ) [64] - Transfection of HEK293 with mutant construct showed increased size of PG (90 kDa) due to ubiquitin binding (WB); cytoplasmic localization of mutant-PG (IF); higher proliferation and lower apoptosis; fewer and smaller desmosomes in mutant PG cells (EM ) [64] -Additional binding properties of mutant PG to TAIP-2 and HRC-BP (Co-IP and yeast-two-hybrid) [64] - Diminished cell stiffness, but not cell adhesion [65]. | Match | n.o. | (het) ACM |
c.201del | p.(Ser68Ala fs*92) | Head domain | P | >PTC > NMD, no protein | Loss of PG?: Highly reduced levels of JUP mRNA (normal splicing), no WB performed [66] | -Absence of PG protein staining in skin biopsies (IF); small desmosomes and wide intercellular spaces (EM) [66]. | Match | (hom)EBS; (hom)PPK; (hom) alopecia | (hom) ACM |
c.469-8_469 -1del | p.(Val157_Lys161del) | Armadillo Domain 1 | LP | >Protein expressed -MutPred-Indel> Pathogenic (0.78939) | Unclear; 15 nucleotides shorter cDNA fragments when compared to controls, no WB performed [67]. | Cryptic splice acceptor site activation in exon 4 [67]. | Unclear | n.r. | (het) ACM |
c.1615C > T | p.(Gln539*) | Armadillo Domain 10 | P | >PTC > NMD, no protein - MutPred-LOF> Borderline pathogenic (0.62246) | Loss of PG; No truncated, or full-length PG protein detected in patient’s skin extracts (WB) [68]. -Apart from the strong reduction of JUP (90% reduction), DSP and DSG1 mRNAs were also markedly decreased [68]. | -Complete loss of PG protein in the patient’s skin (WB and IF, both with N-terminal and C-terminal antibody); No skin barrier formation; significant reduction of DP and DG3 in patient skin (IF). Only few, abnormal desmosomes were formed [68]. - Strong reduction PG in the myocardium [68]. | Match | (hom) lethal EBS | n.o. at young age |
c.1729C > T | p.(Arg577Cys) | Armadillo Domain 10 | LP | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> Tolerated -MutPred2> Pathogenic (0.720) | Altered PG function: Mutant PG had similar size as WT and was not reduced on blot according to the study [69]. | -On WB, DG2 and Cx43 protein levels were reduced in mutant expression cells, and desmosomal junctions were destabilized (transfection studies) [69]. | Match | n.r. | (het) ACM |
c.2038_2039del | p.(Trp680Gly fs*11) | Tail domain | P | >PTC > NMD, no protein | Altered PG function; C-terminal truncated PG protein is abundantly expressed (56 aa missing) (WB of biopsied LV and RV of multiple patients) [11,65,70]. | -Reduced Cx43 and PG in patient ventricles and absence of phosphorylated Cx43 (IF; WB). A decreased number of gap junctions in patient’s myocardium (EM) [70]. - Diminishes cell adhesion, but not the cell compliance [65]. -Mouse JUP knockin c.2038_2039del [71]. -The mouse data contradict the human data and suggest that mutant mRNA is broken down by NMD in mice, and not much protein is produced (WB does show truncated protein). The authors reason that although the deletion is located in exon 11, the PTC is located in the terminal exon (exon 12) > homozygous mice die at postnatal day 1, while cardiac development went normal, mice had severe skin fragility. -Fusion of the last 5 exons in mice, produced the truncated protein fully, did not cause lethality; however, mice did not develop cardiac dysfunction at 11 months of age. | Mismatch Mismatch human: mice | (hom)PPK; (hom)WH [72] | (hom) ACM [72] |
c.2057_2058del | p.(Met686Asn fs*5) | Tail domain | n.a. | >PTC > NMD, no protein | Altered PG function; Transfected myocytes showed a C-terminal 75 kDa truncated protein (WB) [73]. | Cardiac specific Zebrafish JUPWT/2057_2058del [73]. - The zebrafish mutated myocytes showed significant reduction of INa and IK1 current densities. EM showed disruption of cell–cell contact. (GAL4/UAS transactivation system was used to induce cardiac specific expression of the human 2057_2058del variant in zebrafish) [73]. | Mismatch, but no patients were traced. | n.r. | (hom) ACM claimed, but no patients were traced |
HGVS Nomenclature (DNA) |
HGVS Nomenclature (Protein) | Protein Domain |
ACMG Class |
In Silico Predictions |
Functional mRNA and Protein Studies | Biological Effect |
Prediction: Functional | Skin | Heart |
---|---|---|---|---|---|---|---|---|---|
c.-1445G > C | NC_000018.10:g.31103416C > G | 5′UTR | B | Not applicable (5′UTR), cannot be predicted | Altered DC2 function; n.s. -Luciferase assay >a decreased transcriptional activity for HEK cells transfected with the DC2 mutant (c.-1445C) construct [79]. | Altered transcription factor binding in the presence of the mutant allele. | Mismatch by definition | n.r. | (het) ACM |
c.140_147del | p.(Lys47Arg fs*2) | PRO peptide-domain | LP | >PTC > NMD, no protein | Partial loss of DC2: Patient had reduced levels (>50%) of DC2 in skin biopsy (WB) [80]. | n.r. -of note: a relative with only DSC2:c.1559T > C (missense) had no phenotype [80]. | Match | n.r. | (comp.het) NCCM/HCM with DSC2:c.1559T > C |
c.304G > A | p.(Glu102Lys) | PRO peptide-domain | LB | >Protein expressed -PolyPhen-2> Benign (0.016) -SIFT> Tolerated -MutPred2> Benign (0.158) | Altered DC2 function; n.s., but mutant expressed in cells. | IF shows that the mutant protein localizes in a dotted pattern predominantly in the cytoplasm (COS-1 cells, neonatal rat CM transfection) [81]. | Match | n.r. | (het) ACM |
c.394C > T | p.(Arg132Cys) | In between PRO peptide and EC1-domain | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.823) | Partial loss of DC2; 50% reduced levels of DSC2 mRNA in explanted heart and hiPSC-CMs; reduced DC2 protein in explanted heart (WB) [82] | -Reduced levels of all desmosomal genes in explanted heart and hiPSC-CMs, reduction of PG at ID in heart; mutant hiPSC-CMs had shortened action potential durations associated with reduced calcium current density and increased potassium current density [82]. -Increased PPARƴ expression and contractile and electric disturbances observed in patient hiPSC-CMs [83] -Zebrafish DSC2WT/c.394C > T [82]. | Mismatch | n.r. | (het) ACM |
c.609C > T | p.(Arg203Cys) | EC1 domain | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.899) | Altered DC2 function; Complete defect in processing into the mature form [84]. (WB) | -The mutant protein remains in an unprocessed pro-protein form (COS-1 cells transfection) [84]. -In HL-1 cells, the mutant protein fails to localize at the desmosomes of intercalated disc structures [84]. | Match | n.r. | (het) ACM |
c.631-2A > G | p.(Ile211Met fs*11) | EC1 domain | P | >PTC > NMD, no protein | Partial loss of DC2: Patient heart tissue shows 60% DC2 reduction (WB) [85] -Reduced mRNA DSC2 (only 3% compared to WT) [85] | -n.r. -Zebrafish KD of DSC2 and DSC2WT/631−2A > G [85]. | Match | n.o. | (het) ACM |
c.824C > T | p.(Thr275Met) | EC2 domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.999) -SIFT> NOT tolerated -MutPred2> Benign (0.563) | Altered DC2 function; Partial defects in processing into the mature form [84]. (WB) | -Only a proportion of the partly functional DC2 mutant protein is still incorporated into the desmosomes; affects PG at the intercalated disc (COS-1 cells transfection) [84]. | Match | n.r. | (hom) ACM |
c.1034T > C | p.(Ile345Thr) | EC2 domain | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.756) -SIFT> NOT tolerated -MutPred2> Benign (0.591) | Altered DC2 function; n.s., but mutant expressed in cells. | -In transfected neonatal rat cardiomyocytes and HL-1 cells, the mutant protein localizes in the cytoplasm (IF) [81]. | Match | n.r. | (het) ACM |
c.1559T > C | p.(Ile520Thr) | EC4 domain | LB | >Protein expressed -PolyPhen-2> Probably damaging (0.973) -SIFT> NOT tolerated -MutPred2> Benign (0.601) | Altered DC2 function; Protein is expressed, similar size as wildtype (WB) [80]. Unsure if the protein is really altered, or that it maintains all functions [80]. | n.r. -of note: a relative with only DSC2:c.1559T > C (missense) had no phenotype [80]. | Match | n.r. | (comp.het) NCCM/HCM with DSC2:c.140_147del |
c.1660C > T | p.(Gln554*) | EC4 domain | P | >PTC > NMD, no protein -MutPredLOF> borderline pathogenic (0.51161) | Altered DC2 function; Truncated DC2 protein (75 kDa), wildtype is 150 kDa (transfection WB). Less mature protein, more pre-protein than normal [86]. | -Heart biopsies shows DC2 staining in hom-carriers (protein is expressed); mutant protein localizes only partially at cell membrane and predominantly in cytoplasm (transfection IF WB) [86]. -Transfected cells show that the secreted truncated isoforms are not anchored in the plasma membrane [87]. | Mismatch | Mild PPK at pressure points, in one hom- and one het-carrier (possibly secondary to farm work) | (hom) ACM (LV affected mainly) |
c.1841del | p.(Ser614Ile fs*11) | EA domain | P | >PTC > NMD, no protein | Unclear?; Truncated isoforms expressed (transfection IF, WB), but needs patient cell confirmation. | Transfected cells show that the secreted truncated isoforms are not anchored in the plasma membrane [87]. | Unclear | (hom) Mild PPK, WH [88] | (hom) ACM [88] |
c.1913_1916 del | p.(Gln638Leu fs*9) | EA domain | P | >PTC > NMD, no protein | Partial loss of DC2: Strong DC2 protein reduction in patient heart tissue (<10% left-WB, also IF) [87]. -DSC2 mRNA was decreased in patient heart tissue (qPCR) | -Patients’ explanted heart shows degradation of sarcomeres and mitochondria; widened intercellular spaces and accumulation of lipid droplets (EM); Transfected cells show that the secreted truncated isoforms are not anchored in the plasma membrane [87]. | Match | n.o. | (hom) ACM |
c.2368_2370 del | p.(Gly790del) | In between IA and ICS domains | US | >Protein expressed -MutPred-Indel> NOT pathogenic (0.4309) | Altered DC2 function: No reduction of DC2 protein levels [89]. | -Slight LV dysfunction with abnormal calcium release [89]. -Mouse model > [89] Hom-mice (G790del) showed enlarged LV and a decreased fractional shortening. Abnormal intracellular calcium release, but no clear ACM phenotype. Het-mice showed no arrhythmias. | Match | n.r. | (het) CM |
c.2553del | p.(Asp852Thr fs*4) | ICS domain DC2a only | US | -PTC > terminal exon, not NMD > protein expressed | Altered DC2a function; Truncation of the last 47 aa of the DC2a isoform [90]. | The mutant protein DC2a lost its ability to bind to PG (HL-1 cells transfection) [90]. | Match | n.r. | (het) ACM |
c.2687_2688 insGA | p.(Ala897Lys fs*4) | ICS domain DC2a only | B | -PTC > terminal exon, not NMD > protein expressed | Altered DC2a function; -Premature termination of the protein [91]. -Does not exhibit defects in processing into the mature form [84]. | -Cytoplasmic localization of the mutant protein (HL-1 cells transfection) [91]. -This mutant protein is processed into its mature form and can be incorporated into desmosomes; impaired binding to DP and PG (COS-1 cells transfection) [84]/ | Match | n.r. | (het) ACM |
HGVS Nomenclature (DNA) |
HGVS Nomenclature (Protein) | Protein Domain |
ACMG Class |
In Silico Predictions |
Functional mRNA and Protein Studies | Biological Effect |
Prediction: Functional | Skin | Heart |
---|---|---|---|---|---|---|---|---|---|
c.1A > T | p.(Val2_Met29del) | Pre-N-terminal | P | >No protein, loss of start-codon -PolyPhen-2> Benign (0.267) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.881) | Altered KLHL24 function; N-terminally truncated protein (28 aa shorter protein, transfection WB). Translation initiation at Met29. | More stable KLHL24 mutant protein which no longer undergoes autoubiquitination. Excessive ubiquitination keratin 14 [98,100] | Mismatch | (het) EBS; (het) PPK | (het) DCM |
c.1A > G | p.Val2_Met29del | Pre-N-terminal | P | >No protein, loss of start-codon -PolyPhen-2> Benign (0.267) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.898) | Altered KLHL24 function; N-terminally truncated protein (28 aa shorter protein, transfection WB). Translation initiation at Met29. mRNA expression levels not different from WT [98,100,101] | -More stable KLHL24 mutant protein which no longer undergoes autoubiquitination. Excessive ubiquitination keratin 14 [98,100]. -Excessive breakdown of keratin 14 in patient foetal-like hiPSC-derived keratinocytes, otherwise not observed in adult primary keratinocytes [102]. -Excessive ubiquitination of desmin (10% desmin levels left in hiPSC-derived dynamic EHTs). Both RNAi of KLHL24 and overexpression of desmin rescued the in vitro phenotype [101]. | Mismatch | (het) EBS; (het) PPK; (het) Alopecia | (het) DCM |
c.2T > C | p.Val2_Met29del | Pre-N-terminal | P | > No protein, loss of start-codon -PolyPhen-2> Possibly damaging (0.599) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.929) | Altered KLHL24 function; N-terminally truncated (28 aa shorter protein, transfection WB); Translation initiation at Met29. mRNA expression levels not different from WT. | -More stable KLHL24 mutant protein which no longer undergoes autoubiquitination. Excessive ubiquitination keratin 14 [98,100] -Keratins 7,8,17 and 18 were also subjected to KLHL24-mediated degradation in a foetal keratinocyte cell model [103]. | Mismatch | (het) EBS; (het) PPK; (het) Alopecia | (het) DCM |
c.3G > A | p.Val2_Met29del | Pre-N-terminal | P | > No protein, loss of start-codon -PolyPhen-2> Benign (0.380) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.919) | Altered KLHL24 function; N-terminally truncated protein (28 aa shorter protein, transfection WB). Translation initiation at Met29. | More stable KLHL24 mutant protein which no longer undergoes autoubiquitination. Excessive ubiquitination keratin 14 [98,100] | Mismatch | (het) EBS; (het) PPK | (het) DCM |
c.3G > T | p.Val2_Met29del | Pre-N-terminal | P | > No protein, loss of start-codon -PolyPhen-2> Benign (0.380) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.919) | Altered KLHL24 function; N-terminally truncated protein (28 aa shorter protein, transfection WB). Translation initiation at Met29. | -More stable KLHL24 mutant protein which no longer undergoes autoubiquitination. Excessive ubiquitination keratin 14 [98,100] Excessive ubiquitination of keratin 15 in hair follicle stem cells causes alopecia in mice [104]. Mouse KLHL24WT/3G > T [98,104] | Mismatch | (het) EBS; (het) PPK; (het) Alopecia | (het) DCM |
c.22A > T | p.Val2_Met29del not p.(Arg8*) | N- terminal | P | >PTC > NMD, no protein | Altered KLHL24 function; N-terminally truncated protein (28 aa shorter protein, transfection WB). Translation re-initiation at Met29 after uORF (Met1_Arg8*) [105] | More stable KLHL24 mutant protein. Excessive ubiquitination of desmin (IF) [105]. | Mismatch | (het) EBS | (het) DCM |
c.917G > A | p.(Arg306His) | before KR | US | >Protein expressed -PolyPhen-2> Probably damaging (0.999) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.740) | n.r. (loss of KLHL24 suggested) It is unclear if this protein is expressed or degraded (no WB), but protein activity is expected to be lost. | Higher desmin expression in myocardial biopsies (WB). Ubiquitination loss Desmin? [106,107] (KD KLHL24 zebrafish) [106] | Unclear | n.o. | (hom) HCM |
c.1048G > T | p.(Glu350*) | Kelch repeat (KR1) | P | >PTC > NMD, no protein -MutPred-LOF> NOT pathogenic (0.30843) | n.r. (loss of KLHL24 suggested) It is unclear if this protein is expressed or degraded (no WB), but protein activity is lost. | Higher desmin expression in myocardial biopsies (WB). Ubiquitination loss Desmin? [106,107] (KD KLHL24 zebrafish) [106] | Probable match | n.o. | (hom) HCM |
HGVS Nomenclature (DNA) |
HGVS Nomenclature (Protein) |
Protein Domain | ACMG Class |
In Silico Predictions |
Functional mRNA and Protein Studies | Biological Effect |
Prediction: Functional |
Skin (PPK and Hair Only) | Heart |
---|---|---|---|---|---|---|---|---|---|
c.5G > T | p.(Gly2Val) | N-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.992) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.769) | Altered Cx43 function; n.r., but mutant is expressed. | Impaired channel transfer function. Mutant protein inhibits wt-Cx43.Unable to form functional channels [118]. | Match | n.r. | n.r. |
c.7G > A | p.(Asp3Asn) | N-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.993) -SIFT> NOT tolerated -MutPred2> Benign (0.413) | Altered Cx43 function; n.r., but mutant is expressed. | -Impaired channel transfer function [118,119]. -Mutant protein inhibits wt-Cx43 [118]. -Deficient fibroblast migration, proliferation and differentiation (impaired healing) [119] | Match | n.r. | n.r. |
c.19T > G | p.(Leu7Val) | N-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.999) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.662) | Altered Cx43 function; n.r., but mutant is expressed. -Greatly reduced total Cx43 levels (<25% of WT) (WB) -Significantly reduced GJA1 mRNA expression (<25% of WT) (qPCR) | -Impaired phosphorylation. Shortened gap junction length. Severely reduced intercellular electrical coupling. Dysregulation of cell growth, migration and polarization [120]. -Impaired channel transfer function. Mutant protein inhibits wt-Cx43 [118]. | Match | n.r. | n.r. |
c.23G > T | p.(Gly8Val) | N-terminal cytoplasmic domain | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.913) -SIFT> Tolerated -MutPred2> Benign (0.566) | Altered Cx43 function; n.r., but mutant is expressed. | -Augmented hemichannel activity [121]. -Increased keratinocyte cell death and apoptosis [122]. | Match | (het) PPK; (het) alopecia | n.r. |
c.32T > C | p.(Leu11Pro) | N-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.951) | Altered Cx43 function; n.r., but mutant is expressed. | Translocation of protein from the junctions to the cytoplasm and Golgi network. Impaired channel transfer function. Mutant protein inhibits wt-Cx43 [118]. | Match | (het) WH; abnormal hair shaft; keratoderma | n.r. |
c.50A > C | p.(Tyr17Ser) | N-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.955) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.889) | Altered Cx43 function; n.r., but mutant is expressed. | -Impaired channel transfer function [118,123]. -Complete loss of intercellular electrical coupling [123]. -Inhibited migration [124]. -Translocation of protein from the junctions to the cytoplasm and Golgi network. Mutant protein inhibits wt-Cx43 [118]. | Match | n.r. | n.r. |
c.52T > C | p.(Ser18Pro) | N-terminal cytoplasmic domain | LP | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.946) | Altered Cx43 function; n.r., but mutant is expressed. | Translocation of protein from the junctions to the cytoplasm and Golgi network. Impaired channel transfer function. Mutant protein inhibits wt-Cx43 [118]. | Match | n.r. | n.r. |
c.61G > A | p.(Gly21Arg) | TM1 | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.972) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.784) | Altered Cx43 function; n.r., but mutant is expressed. | -Complete loss of intercellular electrical coupling [123]. -Reduced channel conductance [125,126]. -Mutant protein inhibits wt-Cx43 [125,126,127] | Match | n.r. | (het) Heart developmental formation |
c.93T > G | p.(Ile31Met) | TM1 | US | >Protein expressed -PolyPhen-2> Probably damaging (0.980) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.854) | Altered Cx43 function; n.r., but mutant is expressed. | Impaired phosphorylation. Inhibited gap junctional coupling. Augmented hemichannel activity [128]. | Match | n.r. | n.r. |
c.97C > T | p.(Arg33*) | TM1 | LP | -PTC- only 1 exon, not NMD > protein expressed -MutPred-LOF> Pathogenic (0.64454) | Altered Cx43 function; n.r., but mutant is expressed. | -Translocation of protein from the junctions to the cytoplasm and nucleus. Unable to form functional channels [129]. | Match | n.r. | n.r. |
c.119C > T | p.(Ala40Val) | TM1 | US | >Protein expressed -PolyPhen-2> Probably damaging (0.990) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.841) | Altered Cx43 function; n.r., but mutant is expressed. | Impaired channel transfer function. Complete loss of intercellular electrical coupling [123]. | Match | n.r. | n.r. |
c.124G > A | p.(Glu42Lys) | E1 | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.993) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.885) | Altered Cx43 function; n.r., but mutant is expressed. | -Complete loss of intercellular electrical coupling. Areas with complete loss of protein signal in immunohistochemical staining (mosaicism) [130] -GJA1c.124G > A/WT mouse model [131] | Match | n.r. | (het) Cardiac arrhythmias |
c.131C > T | p.(Ala44Val) | E1 | LP | >Protein expressed -PolyPhen-2> Benign (0.140) -SIFT> Tolerated -MutPred2> Pathogenic (0.709) | Altered Cx43 function; n.r., but mutant is expressed. | -Augmented hemichannel activity [121]. -Translocation of protein from the keratinocyte junctions to the cytoplasm [13]. | Match | (het) PPK; skin keratosis, erythema and naevus | n.r. |
c.145C > A | p.(Gln49Lys) | E1 | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.955) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.866) | Altered Cx43 function; n.r., but mutant is expressed. | Impaired channel transfer function. Mutant protein inhibits wt-Cx43 [126]. | Match | n.r. | n.r. |
c.154_156 dup | p.(Phe52dup) | E1 | US | >Protein expressed -MutPred-Indel> Pathogenic (0.80091) | Altered Cx43 function; n.r., but mutant is expressed. | Unable to produce functional gap junction plaques [123]. | Match | n.r. | n.r. |
n.r. no patients reported with this variant. | p.(Gly60Ser) | E1 | n.a. | >Protein expressed -PolyPhen-2> Probably damaging (0.999) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.915) | Altered Cx43 function; Reduced protein levels of both phosphorylated and total Cx43 protein (WB) [132,133,134,135,136,137]. | -Muscle gap junction intracellular communication severely reduced [132]. -Impaired phosphorylation [138]. -Reduced number of gap junction plaques [133,135]. -Translocation of protein from the junctions to the cytoplasm and Golgi network [133,135,136]. - Reduced intercellular electrical coupling [133,135,137]. -Mutant protein reduces phosphorylation of wt-Cx43 [133,134]. -Arrythmias [139]. -Defective smooth muscle contraction. Impaired reprogramming in response to stretch in smooth muscle [134]. -Impaired bone and teeth development [135,140]. -Increased infarct damage after cerebral artery occlusion [136]. -Enhanced keratinocyte proliferation and differentiation [141]. -Deficient fibroblast migration, proliferation and differentiation (impaired wound healing) [119] -Disturbed hair growth [142]. -GJA1G60S/WT mouse models [134,136,137,138,141,142,143,144,145,146] | Match | WH/ Alopecia in mice. | n.r. |
c.205T > C | p.(Ser69Pro) | E1 | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.869) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.911) | Altered Cx43 function; n.r., but mutant is expressed. | Total loss of membrane transfer capability [147]. | Match | n.r. | n.r. |
c.227G > A | p.(Arg76His) | TM2 | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.690) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.743) | Altered Cx43 function; n.r., but mutant is expressed. | Reduced channel conductance [129]. | Match | (het) Alopecia | n.r. |
c.268C > G | p.(Leu90Val) | TM2 | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.817) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.695) | Altered Cx43 function; n.r., but mutant is expressed. | -Impaired channel transfer function [123]. -Reduced channel conductance [123,126]. -Mutant protein inhibits wt-Cx43 [126]. | Match | n.r. | n.r. |
c.389T > C | p.(Ile130Thr) | Cytoplasmic loop domain | LP | >Protein expressed -PolyPhen-2> Benign (0.013) -SIFT> Tolerated -MutPred2> Benign (0.506) | Altered Cx43 function: Reduced Cx43 protein total and phosphorylated levels compared to WT (WB) [134,138,148]. | -Impaired channel transfer function [123,134]. -Reduced channel conductance [123,148]. -Defective smooth muscle contraction. Impaired reprogramming in response to stretch in smooth muscle [134]. -Impaired phosphorylation [138]. -Slower cardiac conduction velocity. Electrocardiogram abnormalities and arrhythmias in vivo and ex vivo [148] -GJA1I130T/WT mouse model [134,138,144,148] | Match | n.r. | (het) Ventricular tachycardia; Arrhythmia Atrioventricular block [149] |
c.400A > G | p.(Lys134Glu) | Cytoplasmic loop domain | US | >Protein expressed -PolyPhen-2> Benign (0.002) -SIFT> Tolerated -MutPred2> Benign (0.570) | Altered Cx43 function; n.r., but mutant is expressed. | Impaired channel transfer function. Reduced channel conductance [123]. | Match | (het) PPK | n.r. |
c.412G > C | p.(Gly138Arg) | Cytoplasmic loop domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.985) -SIFT> Tolerated -MutPred2> Benign (0.462) | Altered Cx43 function; n.r., but mutant is expressed. -Significantly reduced total Cx43 (<70% of WT) and phosphorylated levels (WB) [120,150]. | -Impaired phosphorylation [120,128]. -Shortened gap junction length [128]. -Reduced number of gap junction plaques [148]. -Reduced channel conductance [125]. -Dysregulation of cell growth, migration and polarization [120]. -Mutant protein inhibits wt-Cx43 [125,127]. -Unable to form functional channels [127,150]. -Electrocardiogram abnormalities and arrhythmias in vivo and ex vivo [150]. -Inhibited gap junctional coupling [128,148]. -Augmented hemichannel activity. Increased half-time of Cx43 protein [128]. -Altered expression of Shh and Bmp2 [151]. GJA1WT/c.412G > C mouse model [150,151]. | Match | (het) PPK; (het) Alopecia | (het) Arrhythmia. |
c.427G > A | p.(Gly143Ser) | Cytoplasmic loop domain | US | >Protein expressed PolyPhen-2> Possibly damaging (0.788) -SIFT> Tolerated -MutPred2> Benign (0.604) | Altered Cx43 function; n.o. mutant is expressed, but size and amount is similar at WT (WB). -mRNA levels are similar as WT. | -Impaired phosphorylation [120,128]. -Dysregulation of cell growth, migration and polarization [120]. -Inhibited gap junctional coupling. Augmented hemichannel activity. Increased half-time of Cx43 protein [128]. | Match | (het) WH/ Alopecia | n.r. |
c.440T > C | p.(Met147Thr) | Cytoplasmic loop domain | US | >Protein expressed PolyPhen-2> Probably damaging (0.979) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.822) | Altered Cx43 function; n.r., but mutant is expressed (transfection). | -Retains α-helical structure, but exhibits loss of function and cellular trafficking defects [152]. | Match | (het) Alopecia | n.r. |
c.443G > A | p.(Arg148Gln) | Cytoplasmic loop domain | US | >Protein expressed PolyPhen-2> Possibly damaging (0.773) -SIFT> Tolerated -MutPred2> Benign (0.442) | Altered Cx43 function; n.r., but mutant is expressed (transfection). | -Retains α-helical structure, but exhibits loss of function and cellular trafficking defects [152]. | Match | n.r. | n.o. |
c.460A > G | p.(Thr154Ala) | Cytoplasmic loop domain | LP | >Protein expressed PolyPhen-2> Possibly damaging (0.662) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.660) | Altered Cx43 function; n.r. but mutant is expressed (transfection). | -Retains α-helical structure, but exhibits loss of function and cellular trafficking defects [152]. | Match | (het) dry hair, thin skin | (het) Ventricular septal defects; extrasystoles |
c.581A > C | p.(His194Pro) | E2 | LP | >Protein expressed -PolyPhen-2> Probably damaging (0.939) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.909) | Altered Cx43 function; n.r., but mutant is expressed. | Impaired phosphorylation. Inhibited gap junctional coupling. Augmented hemichannel activity [128]. | Match | n.r. | n.r. |
c.605G > A | p.(Arg202His) | E2 | US | >Protein expressed -PolyPhen-2> Probably damaging (1.000) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.819) | Altered Cx43 function; n.r., but mutant is expressed. | -Unable to produce functional gap junction plaques. Decreased permeability [123]. -Reduced channel conductance. Translocation of protein from the junctions to the cytoplasm and Golgi network. Mutant protein inhibits wt-Cx43 [126]. | Match | n.r. | n.r. |
c.646G > T | p.(Val216Leu) | TM4 | US | >Protein expressed -PolyPhen-2> Possibly damaging (0.869) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.760) | Altered Cx43 function; n.r., but mutant is expressed. -Reduced protein levels in hiPSC (WB) [153]. -Reduced mRNA levels in hiPSC [153]. | -Impaired channel transfer function [119,153]. -Deficient fibroblast migration, proliferation and differentiation (impaired wound healing) [119] -Delayed osteoblast differentiation [153]. -Reduced channel conductance. Translocation of protein from the junctions to the cytoplasm and Golgi network. Mutant protein inhibits wt-Cx43 [126]. | Match | n.r. | n.r. |
c.681A > T | p.(Glu227Asp) | TM4 | LP | >Protein expressed -PolyPhen-2> Possibly damaging (0.900) -SIFT> NOT tolerated -MutPred2> Pathogenic (0.811) | Altered Cx43 function; n.r., but mutant is expressed. | -Augmented hemichannel activity [121]. -Translocation of protein from the keratinocyte junctions to the cytoplasm [13]. | Match | (het) Skin keratosis and erythema | n.r. |
n.r. | p.(Lys258*) | C-terminal cytoplasmic domain | n.a. | -PTC > NOT NMD -MutPred-LOF> Pathogenic (0.63488) | Altered Cx43 function; n.r., but mutant is expressed. | -Increased keratinization and unstable skin structure [154]. -GJA1K258S*/WT mouse model [154,155] | Match | n.r. | n.r. |
c.780_781del | p.(Cys260Trp fs*47) | C-terminal cytoplasmic domain | LP | -PTC- only 1 exon, not NMD > protein expressed | Altered Cx43 function; Produced a shortened 305 residues instead of a 382 wt-Cx43 | Reduced number of gap junction plaques. Severely reduced intercellular electrical coupling. Mutant protein inhibits wt-Cx43 in a dose-dependent manner [156]. | Match | (het) PPK | n.r. |
c.848C > T | p.(Pro283Leu) | C-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.997) -SIFT> Tolerated -MutPred2> Pathogenic (0.690) | Altered Cx43 function; n.r., but mutant is expressed. | -Translocation of protein from the keratinocyte junctions to the cytomembrane and cytoplasm [157]. - Formed functional gap junction channels, with no evidence of augmented hemichannel function or induction of cell death (transfection) [158]. | Match | (het) PPK; skin keratosis and erythema | n.r. |
c.869C > A | p.(Thr290Asn) | C-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.976) -SIFT> Tolerated -MutPred2> Benign (0.308) | Altered Cx43 function; n.r., but mutant is expressed. | -Translocation of protein from the intracellular keratinocyte junctions to the cytomembrane and cytoplasm [157]. -Formed functional gap junction channels, with no evidence of augmented hemichannel function or induction of cell death (transfection) [158]. | Match | (het) PPK; skin keratosis and erythema | n.r. |
c.932del | p.(Ala311Val fs*37) | C-terminal cytoplasmic domain | US | -PTC- only 1 exon, not NMD > protein expressed | Altered Cx43 function; n.r., but mutant is expressed. | -Significant inhibition of membrane transfer capability [147]. -Translocation of protein from the junctions to the cytoplasm and Golgi network. Severely reduced intercellular electrical coupling. Genetic mosaicism [159]. | Match | n.r. | (het) Atrial fibrillation [159] |
c.977C > T | p.(Thr326Ile) | C-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Probably damaging (0.975) -SIFT> NOT tolerated -MutPred2> Benign (0.326) | Altered Cx43 function; n.r., but mutant is expressed. | Total loss of membrane transfer capability [147]. | Match | n.r. | n.r. |
n.r. | p.(Ser364Pro) | C-terminal cytoplasmic domain | US | >Protein expressed -PolyPhen-2> Benign (0.000) -SIFT> Tolerated -MutPred2> Benign (0.315) | Altered Cx43 function; n.r., but mutant is expressed. | -Abnormalities in phosphorylation and cell–cell communication [160]. -Impaired pH sensitivity [161]. | Match | n.r. | (het) Heart developmental formation |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vermeer, M.C.S.C.; Andrei, D.; Marsili, L.; van Tintelen, J.P.; Silljé, H.H.W.; van den Berg, M.P.; van der Meer, P.; Bolling, M.C. Towards a Better Understanding of Genotype–Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction. Int. J. Mol. Sci. 2022, 23, 10765. https://doi.org/10.3390/ijms231810765
Vermeer MCSC, Andrei D, Marsili L, van Tintelen JP, Silljé HHW, van den Berg MP, van der Meer P, Bolling MC. Towards a Better Understanding of Genotype–Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction. International Journal of Molecular Sciences. 2022; 23(18):10765. https://doi.org/10.3390/ijms231810765
Chicago/Turabian StyleVermeer, Mathilde C. S. C., Daniela Andrei, Luisa Marsili, J. Peter van Tintelen, Herman H. W. Silljé, Maarten P. van den Berg, Peter van der Meer, and Maria C. Bolling. 2022. "Towards a Better Understanding of Genotype–Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction" International Journal of Molecular Sciences 23, no. 18: 10765. https://doi.org/10.3390/ijms231810765